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ABSTRACT 
THE EFFECTS OF BOVINE VIRAL DIARRHEA VIRUS AND BOVINE 
HERPESVIRUS TYPE 1 ON MONOCYTE-DERIVED DENDRITIC CELLS 
JACOB SOBRASKE 
2018 
 Bovine viral diarrhea virus (BVDV) and bovine herpesvirus type 1 (BHV-1) are 
important pathogens that affect cattle.  In this in vitro study, the main goal was 
determining the direct effects of BVDV and BHV-1 infections of monocyte-derived 
dendritic cells (MDDC) on cytokine mRNA expression.  For the BVDV infected MDDC 
experiments, Holstein Friesian and Brown Swiss calves were included with a breed 
comparison with cytokine expression. Surface marker expression was also measured in 
BHV-1-infected MDDCs.  For both viruses, a high virulent strain (1373 for BVDV and 
Cooper for BHV-1) and lower virulent strains (20508 for BVDV and Los Angeles for 
BHV-1) were used.  Ten cytokines: interferon-alpha (IFN-alpha), interferon-beta (IFN-
beta), interferon-gamma (IFN-gamma), interleukin-1a (IL-1a), interleukin-1b (IL-1b), 
interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-12 (IL-12), 
and tumor necrosis factor (TNF) were measured.  BVDV infection of MDDCs down 
regulated all cytokine mRNA compared to the control.  IL-1b had the greatest down 
regulation with more than a 40-fold decrease.  The three IFN cytokines had less than a 2-
fold decrease.  The other IL cytokines had less than 10-fold decreases.  Five cytokines 
expressed by BHV-1 infected MDDCs were down regulated.  The IFN family were up 
regulated.  IFN-alpha had greater than a 10-fold increase, IFN-beta had greater than a 3-
fold increase, and IFN-gamma had less than a 1-fold increase.  The other 5 IL cytokines 
xiii 
  
were down regulated with less than a 4-fold decrease.  For both BVDV and BHV-1, IFN-
alpha and IL-8 showed statistical significance between the two strains.  There was a 
difference for the 2 BVDV strains for 2 cytokines: BVDV 1373 down regulated both 
IFN-Alpha and IL-8 more than 28508.  BHV-1 Cooper strain up regulated IFN-Alpha 
and down regulated IL-8 as compared to the Los Angeles strain.  For the breed 
comparison study with BVDV, Brown Swiss calves had higher MDDC yields than 
Holstein Friesian calves after MDDC preparation.  Cytokine mRNA expression had a 
greater up regulation and less down regulation in Holstein Friesian calves.  Finally, BHV-
1 infection of MDDC resulted in decreased MHCI, MHCII, and CD86 surface marker 
expression.  Future studies will analyze the effect of infection on antigen presentation and 
stimulation of naïve T cells. 
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CHAPTER 1: RESEARCH OBJECTIVES AND LITERATURE REVIEW 
INTRODUCTION 
 BVDV and BHV-1 are viral pathogens of cattle that infect both dairy and beef 
cattle.  BVDV and BHV-1 infections cause severe economic losses to the industry.  Both 
viruses are associated with respiratory and reproductive disease.  The effect that 
cytokines have on the immune system are an important area of study.  Cytokines play 
important roles in regulation of cells and infections.  The study of the effect of two 
common cattle viruses on monocyte-derived dendritic cells (MDDC)  and the production 
of cytokines is important.  Dendritic cells are the major cells required for the immune 
response as they present antigens and stimulate the adaptive immune system.  Studying 
the in vitro effect of BVDV or BHV-1 on MDDCs will help in understanding the immune 
responses in infected cattle or cattle vaccinated with modified live BVDV and/or BHV-1 
vaccines. 
 
RESEARCH GOAL AND OBJECTIVES 
 The overall goal of this research was to provide new information regarding 
cytokine expression and surface marker expression of virally infected MDDCs.  Specific 
goals were: 
1. Optimizing the in vitro MDDC yields. 
2. Determining the effect of BVDV or BHV-1 infection on MDDCs mRNA cytokine 
expression. 
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3. Determining the effect of breed MDDC response to BVDV infection on cytokine 
expression. 
4. Determining the effect of BHV-1 virally infected MDDC surface marker expression. 
 
LITERATURE REVIEW  
1. Bovine Viral Diarrhea Virus 
1.1 BVDV Viral Structure and Replication 
 Bovine Viral Diarrhea Virus (BVDV) is a small, enveloped, single stranded RNA 
virus.  The BVDV genome is only about 12.3 Kbp in length (Baule, et al., 1997) (Fig 
1.1.).  It comes from an unassigned order, the family Flaviviridae and the genus 
Pestivirus.  This family also includes the genera Flavivirus and Hepacivirus that are 
similar to Pestivirus (Nettleton and Entrican, 1995; Thiel, 1996).  Each of the three 
genera, have different viruses associated with them.  The genus Flavivirus includes 
dengue virus, Japanese encephalitis virus, St. Louis encephalitis virus, West Nile virus, 
and yellow fever virus.  The genus Hepacivirus contains only the hepatitis C virus.  
Finally, the genus Pestivirus contains border disease virus, classical swine fever virus, 
bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2.  All of the Pestivirus 
genus are non-zoonotic (Mayo, 2002).  The genome of BVDV contains one single open 
reading frame (ORF) containing approximately 4,000 codons, which yields 10 or 11 
posttranslational cleaved proteins.  At both 5' and 3' ends, there are untranslated regions 
(Donis, 1995).  The 5' untranslated region (5' UTR) is essential for viral replication, while 
the 3' untranslated region (3' UTR) is for the viral replication termination.  The translation 
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occurs when a CAP independent mechanism is able to enter the internal ribosomal entry 
site (IRES) located in the 5' UTR (Frolov, et al., 1998; Isken, et al., 2004).  The structural 
proteins and the nonstructural proteins are encoded in different regions.  The 5' 1/3 of the 
genome encodes structural proteins and the 3' 2/3 of the genome encodes non-structural 
proteins (Collet, et al., 1988).  There are four structural proteins: the capsid protein (C), 
and three surface glycoproteins expressed in the envelope; Erns (envelope protein with 
RNAse activity), E1, and E2 (Steck, et al., 1980).  There are eight non-structural (NS) 
proteins: Npro (non-structural protease), NS2, NS3, NS4A, NS4B, NS5A, NS5B, and 
NS23 (Tamura, et al., 1993).  NS23 is a protein that differs between cytopathic and 
noncytopathic strains of BVDV.  The protein is cleaved in cytopathic strains becoming 
NS2 and NS3, but remains NS23 in noncytopathic strains (Ridpath and Bolin, 1995).  In 
the genome, the proteins are organized 5' to 3': Npro, C, Erns, E1, E2, p7, NS23, NS4A, 
NS4B, NS5A, NS5B (Pocock et al., 1987) (Fig. 1.2.).  Each of the proteins serve a 
specific purpose.  Npro is an autoprotease, a protease that cleaves itself, causing the C 
protein to be cleaved (Wiskerchen and Collett, 1991).  Erns degrades the double stranded 
RNA (dsRNA) structures that accumulate during infection using its RNase domain.  This 
is important as the lack of dsRNA prevents toll-like receptor 3 and RIG-1-like receptors 
from detecting the viral infection (Meyers et al., 2007).  The E2 protein is the primary 
antigenic protein, while E1 is secondary (Steck, et al., 1980).  E1 and E2 are surface 
glycoproteins that are in the viral envelope which is the outermost layer of the virion as 
dimers (Fig 1.1.) (Thiel, 1996).  Viral infection is prevented by incubating BVDV with 
anti-E2 antibodies.  This suggests that viral infection occurs through an E2-mediated 
mechanism (Cardoso et al., 2016).  The p7 protein serves as an ion channel for 
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transportation (Griffin, et al., 2003).  NS3 has two important functions.  The N terminal 
encodes a serine protease which functions to assist NS4A that mediates the processing of 
the downstream proteins (Tautz, et al., 1997; Xu, et al., 1997).  The C terminal encodes a 
RNA helicase that is vital in RNA replication (Warrener and Collett. 1995).  NS5A 
contains a serine phosphoprotein that allows interaction with cellular kinases (Reed et al., 
1998).  Finally, NS5B is an RNA polymerase that is viral RNA-dependent (Zhong, et al., 
1998).  NS2 and NS4B proteins are important in viral replication (Behrens, et al., 1998).  
After replication has occurred, BVDV takes the lipid envelope from the host cell that also 
contains E1 and E2 viral glycoproteins (Thiel, 1996). 
1.2 BVDV Genetics and Immunology 
 Bovine viral diarrhea virus strains are classified into two different biotypes and 
two different species.  The biotypes are cytopathic (cp) and noncytopathic (ncp).  The cp 
strains cause pathological changes in an infected cell, while the ncp strains do not cause 
pathological changes in an infected cell (Lee and Gillespie, 1957).  Persistent infection 
(PI) results only when ncp strains but not cp infect the fetus early in pregnancy (Bolin, et 
al., 1985).  Cp strains are associated with mucosal lesions.  Cp strains stimulate the 
immune system, up regulating inflammatory cytokines and causing apoptosis while ncp 
strains down regulate inflammatory cytokines (Brock, 1995; Hoff and Donis, 1997; 
Peterhans et al., 2003; Vivier and Malissen, 2005).  The two species of BVDV are type-1 
and type-2.  They are based on the 5' UTR region, which differs between the two types, 
and is also used for classification into subgroups (Ridpath, et al., 2000).  Type-1 strains 
were the first BVDV strains identified and tend to be less virulent than type-2 (Corapi, et 
al., 1990).  Type-2 strains occur in the most virulent BVDV outbreaks, but can also be 
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found causing less virulent disease (Hamers, et al., 2001).  The strains are also broken 
into subgroups.  Type-1 has 16 subgroups.  Type-2 only has 3 subgroups (Peterhans, et 
al., 2010). 
1.3 BVDV Symptoms 
 There are a number of diseases and symptoms associated with BVDV.  These 
diseases and symptoms depend on the strain, the age, and condition of the host.  Diseases 
caused by BVDV are either acute, chronic, or persistent infection (PI) (Fig 1.3.).  A PI 
animal is an animal that will shed the virus for life.  Acute symptoms are relatively short, 
lasting less than 2 weeks, chronic symptoms last for months, and persistent infections can 
last the life of the animal.  Additionally, mucosal disease and spontaneous abortion are 
associated with BVDV (Radostits, 1985; Brownlie et al., 2000).  Mucosal disease is a 
serious pathological complication that can be caused by BVDV.  It only develops in an 
animal if the animal is persistently infected with a ncp strain, and becomes superinfected 
with a cytopathic strain of BVDV that is similar to the PI ncp strain.  Mucosal disease has 
three forms: acute, chronic, and delayed onset (Bolin, 1995).  In the case of acute 
mucosal disease, the disease develops when a cp BVDV strain that is homologous to the 
PI ncp BVDV strain is present.  As the cp strain is homologous to a ncp strain, the cp 
strain is able to grow without alerting the immune system (Bolin, 1995; Tautz et al., 
1994).  Incubation for an acute infection is one to two weeks and is first observed around 
6 to 18 months of age.  There have been cases observed in younger animals, but these are 
not the norm (Laureyns, et al., 2011).  Symptoms of acute mucosal disease include: 
anorexia, bloody watery diarrhea, decreased milk production, depression, drooling, oral 
erosions, and pyrexia.  Chronic mucosal disease animals usually die.  If the animal 
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recovers, the PI animal will continue to be viremic with the original ncp BVDV strain.  
However, the cp BVDV infection will be cleared.  Chronic mucosal disease symptoms 
include: alopecia, anorexia, bloating, diarrhea, oral erosions, lameness, and weight loss.  
With both acute and chronic mucosal disease, oral erosions are only seen in the most 
severe of cases (Baker, 1995).  The final form of mucosal disease is delayed onset.  
Delayed onset mucosal disease is similar to acute mucosal disease, but is seen after the 
inoculation of the PI animal with a heterologous cp BVDV strain.  This heterologous 
strain is often a modified live cp BVDV vaccine and is seen weeks to months after the 
inoculation (Westenbrink, et al., 1989; Ridpath and Bolin, 1995). 
 The age of the fetus plays an important role in outcome of the BVDV fetal 
infection.  If a fetus is infected in the first 60 days of pregnancy, the pregnancy will likely 
end in an abortion or fetal death.  If the fetus is infected between days 60 and 150, the 
pregnancy will likely yield a PI calf.  It is possible that the fetus does clear the virus.  A 
PI calf may have decreased birth weight, stunted growth, and weight gain, but also may 
appear normal (Fredriksen, et al., 1999; Moennig, et al., 2005).  If the fetus becomes 
infected after 150 days of pregnancy, the immune system of the fetus has developed 
enough to mount an immune response to the BVDV infection.  However, the calves may 
be born with congenital birth defects (Brownlie, et al., 2000).  In addition, congenital 
infection will result in no significant birth defects but may result in increased neonatal 
morbidity and reproductive delay (Muñoz-Zanzi et al., 2003; Muñoz-Zanzi et al., 2004). 
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2. Bovine Herpesvirus-1 
2.1 BHV-1 Viral Structure and Replication 
 Bovine herpesvirus-1 (BHV-1) is a large, enveloped double stranded DNA virus. 
It belongs to the order Herpesvirales, the family Herpesviridae, the subfamily 
Alphaherpesvirinae, and the genus Varicellovirus (Kurjogi, et al., 2012) (Fig 1.4.). There 
are a number of viruses that are closely related to BHV-1.  These include BHV-2,    
BHV-4, BHV-5, equine herpesvirus types 1, 4, and 9 (EHV-1, EHV-4, and EHV-9), 
pseudorabies virus (PRV), and varicella zoster virus (VZV).  Herpes simplex virus (HSV) 
is a distantly related alphaherpesvirus.  BHV-1 is a major virus in the cattle industry and 
is associated with a variety of acute diseases. Diseases include: abortion, conjunctivitis, 
dermatitis, enteritis, encephalitis, infectious balanoposthitis (IPB) in bulls, infertility, 
infectious bovine rhinotracheitis (IBR), infectious pustular vulvovaginitis (IPV) in cows, 
mastitis, and shipping fever (Straub, 2001; Raaperi et al., 2014; Jones, 2003; Tikoo et al., 
1995; Fiorito et al., 2013). BHV-1 infects the host through the conjunctiva, the mucosa of 
the upper respiratory tract, or the reproductive tract. The virus is able to destroy the 
epithelium layer, and enter the blood where it multiples to cause viremia. This viremia 
can spread to additional organs of the body, particularly the central nervous system 
(CNS) and reproductive system (Straub, 1990; Renjifo et al., 1999). The virus infects 
cells by binding to the cell surface and entry is by using viral glycoproteins (gB, gC, gD, 
gE, gH, gK, gL). Not all of the glycoproteins are essential. Glycoproteins gB and gC are 
important to bind heparin sulfate on the host cell and tethers the virus to the cell.  Next, 
BHV-1 gD binds to a virus specific receptor allowing successful infection of a cell (Li et 
at., 1995; Dasika and Letchworth, 1999; Hanon et al., 1999; Schroder and Keil, 1999; 
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Hanon et al., 1998; Tyler and Nathanson, 2001; Li et al., 1996; Biswas et al., 2013; 
Chowdhury and Sharma, 2012; Whitbeck et al., 1996). After the virus has entered the 
cell, the viral nucleocapsid is transported to the nucleus where it uses the host cell 
machinery for DNA replication.  Gene expression is completed in three phases: 
immediate-early (IE), early (E), and late (L).  In IE gene expression, stimulation occurs 
by virion component bTIF.  There are two transcription units in IE transcription.  IE 
transcription unit 1 encodes function homologues of ICP0 and ICP4, while IE 
transcription unit 2 encodes a protein similar to ICP22.  The IE proteins activate E gene 
expression causing viral DNA replication to begin.  The protein bICP0 activates L gene 
expression allowing virion assembly and release (Jones, 2003).  The virus takes the host's 
nuclear envelope, and is then released from the cell. The virus infected cell infects other 
cells as early as 8 hours post infection (p.i.) (Hunter, 2001; Knipe et al., 2001; Biswas et 
al., 2013). An important property of herpesviruses is their ability to establish a latent 
infection. The virus can be reactivated by stressors such as transportation, weaning, 
parturition and then cause symptoms again. The route of infection for BHV-1 determines 
the site of virus latency. It may be latent in the dorsal root ganglia which is most 
common, peripheral blood cells, or the tonsils. Additionally, BHV-1 is able to predispose 
animals to secondary bacterial infections. The virus can also be shed when an animal is 
going through immunosuppression (Fiorito et al., 2013; Winkler et al., 2000; Biswas et 
al., 2013). 
2.2 BHV-1 Genetics and Immunology 
 The Herpesviridae is a very large family of viruses.  There are many different 
herpesviruses that infect many different species of mammals. Latent infection is a feature 
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of all viruses of this family. Latency results in a lifelong possibility that the virus will 
reactivate from its latent state and then spread to other animals of the same species. Three 
areas of biology are of particular importance in learning about herpesviruses: basic 
immunology, latency, and treatments.  Comparative studies are important because 
excessive proinflammatory cytokine production, route of infection, and latency are 
conserved among herpesviruses (Compton et al., 2003; Kurt-Jones et al., 2004; Aravalli 
et al., 2005; Glaser et al., 2006; Waldman et al., 2008; Ariza et al., 2009, 2013; Gregory 
et al., 2012; Ariza et al., 2014). 
 Herpesviridae is further divided into subfamilies for classification according to 
the genetics and tropism of the virus. Subfamilies are alpha (α), beta (β), and gamma (λ) 
(Ariza et al., 2014).  BHV-1 is an α-herpesvirus. Additionally, HSV-1, HSV-2, and VZV 
are also α-herpesviruses. The alpha subfamily is associated with establishing latency in 
neurons (Sloan et al., 2011). Cytomegalovirus (CMV) and human herpesvirus (HHV) 6 
and 7 are β-herpesviruses.  This subfamily establishes latency in leukocytes and the virus 
multiples slower than the other two subfamilies. This is consistent longer incubation 
period these viruses take to show symptoms. Finally, λ -herpesviruses establishes latency 
in immune cells. This subfamily includes the Epstein Barr virus (EBV) and Kaposi’s 
sarcoma-associated herpesvirus (KSHV). As noted, each subfamily has differences, but 
share a similarity in dUTPase enzymatic activity.  The dUTPase genes have different 
sizes and functions, likely indicating evolution played a role in the viruses’ ability to 
interact with the host immune system (Ariza, 2014). By classifying the different 
herpesviruses, it helps to identify the different clinical outcomes.  Within the α-
herpesviruses subfamily, is the Varicellovirus genera, which includes BHV-1. A number 
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of viruses are related to BHV-1. These include BHV-2, BHV-4, BHV-5, pseudorabies 
virus (PRV), equine herpesvirus types 1, 4, and 9 (EHV-1, EHV-4, and EHV-9), and 
VZV. The most similarly related virus to BHV-1 is BHV-5 which was originally known 
as BHV-1.3.  This virus has an 82% amino acid homology with BHV-1.  In addition, it 
establishes latency in sensory ganglia and induces fatal meningoencephalitis in calves 18 
months or younger (Fan et al., 2012; Vogel et al., 2003).  BHV-5 infections occur more 
frequently in South America, but are reported sporadically in Australia.  The similarity 
between BHV-1 and BHV-5 is close enough that BHV-1 vaccines have cross protection 
against BHV-5 (Delhon et al., 2003; Del Medico et al., 2006; Fan et al., 2012). Another 
closely related virus, PRV, is a swine virus that causes Aujeszky’s disease and abortions.  
For swine, PRV infection is most commonly found only in the peripheral nervous system 
(PNS), which can cause mortality of the animal (Lyman et al., 2009).  It is also seen in 
cattle, and is known as mad itch (Li et al., 2014) because it causes rabies-like symptoms. 
These clinical signs include excessive salivation and neurological symptoms.  In cattle, 
the infection doesn't stop at the PNS, but continues from the PNS to the central nervous 
system (CNS) causing the death of the animal (Lyman et al., 2009).  PRV is extensively 
studied in the laboratory as a model for neuronal transmission (Enquist and Card, 2003; 
Lyman et al., 2009). In horses, EHV-1 is very similar to BHV-1 and causes abortion, 
equine herpesvirus myeloencephalopathy (EHM) and respiratory problems (Pusterla et 
al., 2009; Pusterla and Hussey, 2014). Interestingly enough, EHV-4 has an 80% nucleic 
acid similarity, but EHV-4 is less severe than EHV-1.  The virus, EHV-4, only causes 
fever, mild upper respiratory infections and general malaise (Spiesschaert et al., 2015). 
The other similar equine virus, EHV-9, is a neurotropic strain of EHV. Neurotropic 
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indicates that the virus can cause nervous system issues (El-Habashi et al., 2014). For 
human viruses in this family, VZV causes chickenpox (varicella) in children or shingles 
(herpes zoster) in adults that have a latent infection (Sloan et al., 2011). Finally, HSV-1 
and HSV-2 are the most common herpes-viruses in humans. (Koelle and Corey, 2008; 
Bedoui and Greyer, 2014). 
2.3 BHV-1 Symptoms 
 BHV-1 infection symptoms are heavily influenced by the subtype of the virus.  
There are two types of BHV-1: BHV-1.1 and BHV-1.2.  BHV-1.3 is now classified, as 
previously mentioned, as BHV-5.  The most common syndrome associated with BHV-1 
is respiratory disease, which is usually  associated with BHV-1.1.  Respiratory symptoms 
include: serous to mucopurulent discharge from the mouth and nose, fever, and severe 
breathing problems.  If the infected animal becomes infected with bacteria, the symptoms 
can become more severe.  This is seen in bovine respiratory disease complex, which is 
often the result of stress, in combination with a viral infection followed by secondary 
bacterial pneumonia (Biswas et al., 2013).  The other subtype, BHV-1.2, is associated 
with localized genital infections, balanoposthitis in the bull and vulvovaginitis in heifers.  
Interestingly both 1.1 and 1.2 can cause abortion after the fifth month in the gestation 
cycle.  Since BHV-1 causes viremia, the reproductive tract is at risk regardless of the 
subtype and the initial route of infection.  These viruses also infect the ovaries and result 
in necrosis of the corpus luteum.  Additionally, BHV-1.2 can cause frequent urination 
and pustules (Biswas et al., 2013; Brower et al., 2008).  Infection of BHV-1 is hard to 
detect if no symptoms are present.  When symptoms are observed, it is around the fourth 
day post infection (p.i.).  Symptoms will usually last no more than ten days, but 
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additional infection can cause an increase and worsen the infection.  Having an infected 
animal in a herd can cause the virus to spread, so it is important to monitor conditions 
closely (Biswas et al., 2013). 
 
3. Monocyte-Derived Dendritic Cell Biology 
3.1 MDDC Biology 
 Due to the link between the adaptive and innate immune system, dendritic cells 
(DC) are an important area of interest in studying immunology and viral effects on the 
host. A dendritic cell is the most important antigen presenting cell (APC). Classification 
of a DC consists is based on morphology, phenotype, location and function (Summerfield 
et al., 2015). There are a variety of subtypes. These include conventional DCs (cDC; 
previously known as myeloid dendritic cells), plasmacytoid DCs (pDC) and the in vitro 
monocyte-derived dendritic cells (MDDC).  Each of the DCs have a different function; 
cDCs are involved in T cell activation and antigen presentation and pDCs produce large 
quantities of Type I interferon when stimulated with nucleic acids (Summerfield et al., 
2015). Production of DCs isn't the same for each subtype. Both cDCs and pDCs derive 
from common dendritic cell precursors, whereas MDDCs are derived from monocyte 
precursors (Merad et al., 2013). When looking at the location of in vivo DCs, they are 
regulated by monocytes that are circulating throughout the body and can be found in non-
lymphoid organs (Merad et al., 2013).  Studying differentiated DCs  is difficult because 
they can undergo phenotypic changes as they translocate in vivo.  This can alter cell 
surface markers and functions (Summerfield et al., 2015).  Due to the standardized of in 
vitro culture methods for MDDCs, they are an easier DC type for investigation.  Bovine 
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MDDCs are isolated in vitro and used for immunological studies.  The easiest way to 
characterize an immunological cell is to identify surface marker expression.  Each surface 
marker has specific cellular functions and are only found on those cell types.  MDDCs 
are recognized as a DC subset that has the following surface markers: MHCI, MHCII, 
CD1a, CD1b, CD11b, low amounts of CD14, CD86, CD172a, CD205 (Dec 205), and 
CD206 on their surfaces. No CD4, CD11c, CD13, CD21 and CD26 surface markers are 
present (Summerfield et al., 2015). For these studies, MHCI, MHCII, CD14, and CD86 
were measured. DC subsets express different cell surface markers compared to each 
other. This helps classify subsets. MHCI is found on the cell surfaces of all nucleated 
cells. MHCI is important because of the interaction with CD8 found on cytotoxic T cells. 
MHCII is expressed on APCs and is important because of the interaction with CD4 also 
found on T cells. B cells, monocytes and other APCs also express MHCII on their 
surfaces (Benoist and Mathis, 1990; Taylor et al., 1993).  CD86 is a co-stimulatory 
molecule that is up-regulated on the surface of activated DCs (Summerfield et al., 2015). 
CD80 and CD86 are co-receptors found on DCs.  These provide an activation signal 
following MHCII presentation to T lymphocytes to complete DC maturation and 
macrophage and B cell activation (Teichmann et al., 2000; Palomares et al., 2014).  
Another important surface marker is CD14.  CD14 is used to distinguish the level of 
differentiation for monocytes, macrophages, and dendritic cells.  CD14 is a co-receptor 
that interacts with TLR 4 for bacterial LPS (Rajput et al., 2014) and is absent or at low 
levels on DCs.  Dec 205 is a specific marker for DCs (Rajput et al., 2014).  Dec 205 
introduces antigens to the MHCI and MHCII pathways following antigen uptake.  This 
allows presentation to CD4 and CD8 T cells (Shrimpton, 2008).  The phenotype of 
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MDDCs is defined by these cell surface markers (MHCI
+
, MHCII
+
, CD86
+
, CD14
low
, 
DEC205
+
). 
 When a DC activates, cell surface marker expression changes. As MDDCs 
originate as monocytes, there is the expectation to see overlapping of phenotypes. 
Identifying the correct phenotype of bovine DCs is important since different surface 
markers on the cells can cause different outcomes (Rajput et al., 2014). MDDCs are 
distinguishable from macrophages by lower levels of CD14.  Macrophages have high 
levels of CD14 (Mirkovitch et al., 2006; Summerfield et al., 2015). By using GM-CSF 
and IL4, MDDCs differentiate, causing a change in response to LPS stimulation.  This is 
seen with increased expression of MHCI, MHCII, CD80 and CD86, and a decrease in 
CD14 (Summerfield et al., 2015). 
 
4. Cytokines 
4.1 Cytokines 
 A cytokine is a signaling protein produced by many cells of the immune system.  
Cytokines serve to regulate immune responses.  Small cytokines are called chemokines, 
and are also known as chemotatic cytokines (Stenken and Poschenrieder, 2015).  
Classification of cytokines has been done in multiple ways over the years.  Classification 
has been based on both cytokine three-dimensional structure and function, but 
classification is now based only on cytokine receptor three-dimensional structures.  The 
families include: the hemopoietic growth factor (type 1) family, the interferon (type 2) 
family, the tumor necrosis factors (type 3) family, the interleukin-1 receptor family, and 
the interleukin-17 receptor family (Schwartz et al., 2016).  Interferon-alpha (IFN-alpha), 
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Interferon-beta (IFN-beta), Interferon-gamma (IFN-gamma), Tumor Necrosis Factor-
alpha (TNF-alpha), Interleukin-1a (IL-1a), Interleukin-1b (IL-1b), Interleukin-6 (IL-6), 
Interleukin-8 (IL-8), Interleukin-10 (IL-10), and Interleukin-12 (IL-12) were measured in 
MDDCs in these experiments.  Both IFN-alpha and IFN-beta are part of the type 2 
cytokine family and type 1 interferon subgroup.  IFN-alpha is produced by most cells of 
the body and is primarily involved in innate immune responses against a viral infection.  
There are 13 subtypes of IFN-alpha.  IFN-beta is produced by fibroblasts and are 
primarily involved in innate immune responses against a viral infection.  There are 2 
subtypes of IFN-beta (Stenken and Poschenrieder, 2015).  There are also six other IFN 
types: IFN-kappa, IFN-delta, IFN-Epsilon, IFN-tau, IFN-omega, and IFN-zeta (Hardy et 
al., 2004).  IFN-gamma is also part of the type 2 family, but is a type 2 interferon 
subgroup and is produced by leukocytes - particularly NK cells and T cells.  IFN-gamma 
is involved in regulating immune and inflammatory responses, but also has some weak 
antiviral and antitumor effects.  IFN-gamma is able to potentiate the effects of interferon 
type 1.  TNF-alpha is part of the type 3 family.  TNF-alpha is produced by a variety of 
cells, but is primarily produced by macrophages.  It is involved in systemic inflammation 
and is involved in the acute phase reaction.  TNF-alpha has the primary role of immune 
cell regulation.  It is an endogenous pyrogen, a substance that induces fever, but causes 
apoptosis and inhibits tumorigenesis and viral replication.  Both IL-1a and IL-b are part 
of the interleukin-1 family.  They are both produced by a variety of cells such as 
macrophages and dendritic cells.  They are 2 of the 11 cytokines found in this family.  
Both IL-1a and IL-1b are also endogenous pyrogens, but are also able to cause 
vasodilatation, hypotension, and hyperalgesia (Stenken and Poschenrieder, 2015).  
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Additionally, unique to this family, IL-1a and IL-1b are synthesized as a precursor 
protein.  IL-1b is synthesized as precursor protein only after stimulation, but IL-1a does 
not require stimulation (Contassot et al., 2012).  IL-6 and IL-12 are both part of the type 
1 family.  IL-6 is secreted by T-cells and macrophages to help stimulate the immune 
response during infections where it is an important mediator of the acute immune 
response and fever.  It also has an anti-inflammatory activity when it inhibits the effects 
of TNF-alpha, IL-1 and activates IL-10.  IL-12 is produced by a variety of cells including 
macrophages and dendritic cells.  Macrophages produce IL-12 only after antigenic 
stimulation (Stenken and Poschenrieder, 2015).  However, dendritic cells naturally 
produce IL-12 (Kaliński et al., 1997).  IL-12 is a T cell-stimulating factor that is able to 
differentiate naive T cells into Th1 cells (Hsieh, et al., 1993).  IL-12 also stimulates the 
production of IFN-gamma and TNF-alpha from T cells and natural killer cells.  
Additionally, IL-12 is able to enhance the cytotoxic activity of natural killer cells and T 
lymphocytes.  IL-8 is a chemokine that is produced by macrophages.  It is part of the 
CXC chemokine family (Hedges et al., 2000).  IL-8 has two main functions.  These are 
inducing neutrophil chemotaxis and then inducing neutrophil phagocytosis at the target 
site.  The final cytokine is IL-10 is also part of the type 2 family.  It is primarily produced 
by monocytes, and has anti-inflammatory and immunoregulatory effects (Stenken and 
Poschenrieder, 2015). 
 
SUMMARY 
 BVDV and BHV-1 play important roles as disease agents in the cattle industry.  
Both viruses have significant economic consequences.  MDDC studies will hopefully 
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give a better understanding of how cytokine production affects the relationship between 
the innate and adaptive immune systems.  This literature review has covered the major 
areas regarding BVDV, BHV-1, DCs, and cytokines.  The chapters that follow will 
examine each of these categories in more detail.  Chapter 2 covers the optimization of 
MDDC yields and the affect BVDV has on cytokine production of infected MDDCs.  
Chapter 3 covers the affect BHV-1 has on cytokine production on infected MDDCs and 
surface marker expression of infected MDDCs.  Chapter 4 is a general summary of the 
results from the experiments. 
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Fig 1.1. Structure of BVDV: ViralZone 2010, Swiss Institute of Bioinformatics. 
 
Fig 1.2. BVDV encoding proteins: ViralZone 2008, Swiss Institute of Bioinformatics. 
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Fig 1.3. BVDV PI infection: The routes of PI infection in a calf. 
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Fig 1.4. Structure of BHV-1: ViralZone 2017, Swiss Institute of Bioinformatics. 
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CHAPTER 2: MONOCYTE-DERIVED DENDRITIC CELL TECHNIQUE 
OPTIMIZATION AND BOVINE VIRAL DIARRHEA VIRUS CYTOKINE 
ANALYSIS 
ABSTRACT 
 Dendritic cells serve as vital cells in the innate immune system.  When 
functioning normally, dendritic cells produce cytokines that impact other cells in the 
body.  An in vitro study was conducted to determine cytokine production in monocyte-
derived dendritic cells to determine the influence BVDV has on cytokine production.  
Monocytes were first isolated from calf blood and differentiated into monocyte-derived 
dendritic cells.  This was done over a 5-day time period after using IL-4 and GM-CSF to 
stimulate monocyte-derived dendritic cell differentiation.  An optimization process was 
done to maximize the yield of viable monocyte-derived dendritic cells for the 
experiments.  The optimization resulted in around 1x10
6
 MDDCs per mL from the 
starting value of 1x10
5
 per mL.  This increased the yield by 10 times the original value.  
After the optimization was finished, the monocyte-derived dendritic cells were then 
infected with either BVDV strains 1373 or 28508.  The following cytokines were 
measured: IFN-alpha, IFN-beta, IFN-gamma, IL-1a, IL-1b, IL-6, IL-8, IL-10, IL-12, and 
TNF.  Time points were investigated for cytokine up regulation or down regulation at 0h, 
6h, 12h, 24h, and 48h post infection.  BVDV infection of monocyte-derived dendritic 
cells down regulated all cytokine mRNA compared to the control.  IL-1b had the greatest 
down regulation with more than a 40-fold reduction.  The three IFNs had less than a 2-
fold decrease.  The remainder of the IL cytokines and TNF had less than a 10-fold 
decrease.  Both 1373 and 28508 down regulated IFN-alpha, IFN-beta, IFN-gamma, IL-a, 
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IL-1b, IL-6, IL-8, IL-10, IL-12, and TNF with 1373 having a greater down regulation 
than 28508.  Of the cytokines investigated, IL-8 and IFN-alpha had statistically 
significant differences between the two strains.  The remainder of the cytokines tested 
had reduced expression compared to the housekeeping gene controls, but no statistical 
significance between the two strains.  This shows that both viruses interfere with normal 
cytokine production of monocyte-derived dendritic cells. 
 
INTRODUCTION 
 Dendritic cells (DC) are the main antigen presenting cell (APC) in the body.  A 
DC serves to connect the innate immune system to the adaptive immune system by 
presenting antigens to naive T-cells to start the adaptive immune response (Summerfield 
et al., 2015).  Normally DCs are difficult to study due to being in vivo.  By using isolated 
monocytes and adding IL-4 and GM-CSF, monocytes are able to differentiate into 
monocyte-derived dendritic cells (MDDC) in vitro (Rajput et al., 2014).  DCs have 
MHCI, MHCII, CD86, and a decrease in CD14 surface markers that differentiates them 
from other cells (Summerfield et al., 2015). 
 Bovine Viral Diarrhea Virus (BVDV) is a small, enveloped, single stranded RNA 
virus (Baule, et al., 1997).  BVDV strains are classified into two different biotypes and 
two different species.  The biotypes are cytopathic (cp) and noncytopathic (ncp).  A cp 
strain causes pathological changes in cells, while ncp strains don't causes pathological 
changes (Lee and Gillespie, 1957).  The two different species are type 1 and type 2.  Type 
2 are generally thought to be more virulent.  Within each species there are also strain 
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differences.  Within the type 2 ncp viruses, 1373 strain is a highly virulent virus (Liebler-
Tenorio et al., 2002) resulting in high morbidity and high mortality while the 28508 
strain has low morbidity and no mortality (Liebler-Tenorio et al., 2003).  BVDV is 
associated with a number of diseases and symptoms, with persistent infection (PI) of the 
virus being a large problem.  A PI animal will shed the virus for life causing infection of 
other animals in the herd.  Mucosal disease and spontaneous abortion are two diseases 
that have large economic impact that are caused by BVDV (Radostits, 1985; Brownlie et 
al., 2000). 
 Monocytes and MDDCs differ in their interaction with BVDV.  With ncp BVDV, 
monocytes were compromised in allogenic stimulation and CD4+ T-cell responses.  No 
effect was noticed with MDDCs.  Monocytes are killed apoptotically by cp BVDV 
infection, but MDDCs are unaffected.  Stimulation of gene expression of IFN-1 is 
predominantly seen in MDDCs (Reid et al., 2016).  Interferon type 1 (IFN-1) is produced 
in response to BVDV in both in vivo and in vitro.  IFN-Alpha and IFN-Beta are produced 
in cp BVDV-infected cells (Glew, et al., 2003).   Some strains of ncp BVDV have a 
decrease in IFN-Alpha  (Alkheraif, et al., 2017). 
 This study was designed to determine the effect of BVDV in vitro infection on 
MDDCs cytokine mRNA expression.  The susceptibility of MDDCs to BVDV strains 
1373 and 28508 were tested and the cytokine expression was measured for both strains. 
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MATERIALS AND METHODS 
Animals 
 Healthy calves between the ages of 6-8 months housed at the South Dakota State 
University (SDSU) Dairy Farm located in Brookings, SD, USA were used in this study as 
blood donors.  Four calves were used: two Holstein Friesian and two Brown Swiss calves 
were used.  The SDSU Institutional Animal Care and Use Committee approved the 
handling of animals and blood collection.  Blood (~ 250 mL per draw) was collected via 
jugular venipuncture using 60 mL heparinized plastic syringes with 16 gauge 1-1/2 
needles.  All of the calves were confirmed to be BVDV-free using virus isolation 
confirmed with a BVDV immunoperoxidase assay (IPA) (Fulton et al., 1997). 
Peripheral Blood Mononuclear Cell Isolation 
 Peripheral blood mononuclear cells (PBMC) were isolated as previously 
described (Rajput et al., 2014) with modifications.  Two (2) mL of heparin sulfate was 
added to each of 4-60 mL syringes.  The heparin sulfate (Sigma, Sigma Chemicals, St. 
Louis, MO, USA) was made by adding 1 mL of 1000 U/L stock solution to 99 mL of 
phosphate-buffered saline (PBS) to make 100 mL of liquid heparin sulfate at 1000 U/mL 
per mL of PBS.  The syringes were used to collect 250 mL of blood by jugular 
venipuncture from the calves.  After collection, the heparinized blood was layered over 
lymphoprep in SepMate™ lymphoprep 50 mL tubes (Stemcell Technologies, Cambridge, 
MA, USA).  Fifteen (15) mL lymphoprep was added to each SepMate™ tube, to slightly 
cover the insert in the tube.  Around 20 mL of heparinized blood was then layered on top 
of the lymphoprep.  Sixteen (16) SepMate™ tubes were used for each blood collection. 
Each SepMate™ tube containing 35 mL of heparinized blood and lymphoprep were 
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centrifuged at 1200xg for 20 minutes at room temperature using a Beckman J6-MI 
centrifuge.  After centrifugation, with the red blood cells below the insert in the 
SepMate™ tube, the liquid above the insert that contained the buffy coat was poured into 
50 mL conical tubes (Falcon, Oxnard, CA, USA).  After combining all of the buffy coats, 
from the SepMate™ tubes, the tubes were centrifuged at 120xg for 10 minutes at room 
temperature to pellet the cells.  When the cells were pelleted, the supernatant was poured 
into new 50 mL conical tubes.  The pellets were then resuspended in 1 mL of PBS and 
combined into a single conical tube.  This tube was then filled to a total of 50 mL of PBS.  
The tube with the cells from the pellets and the tubes with the liquid poured off were then 
centrifuged at 120xg for 10 minutes at room temperature to wash the cells.  The 
supernatant was disposed and the pellets were all suspended in 1 mL of PBS. The pellets 
were then all added to a single conical tube.  This conical tube was filled with PBS to 50 
mL and centrifuged at 120xg for 10 minutes at room temperature.  The supernatant was 
discarded and the cells were washed 2 or 3 more times to remove the platelets.  When the 
washing was finished, the viability of the PBMCs was determined using trypan blue 
exclusion assay with 0.4% trypan blue stain (Strober, 2001).  The viability of the 
monocytes was calculated using the formula: cell viability % = number of viable cells X 
100/total counted cells.  The viable cells were the cells not stained by trypan blue, while 
the non-viable cells were stained by trypan blue.  The pellet of PBMCs was suspended in 
1 mL of a mixture containing Roswell Park Memorial Institute (RPMI) 1640 medium 
(GE Healthcare, Hyclone Laboratories, Logan, UT, USA), penicillin (100 U/mL) and 
streptomycin (100 μg/mL).  The cells were then divided into 4 conical tubes with 4 mL of 
FBS (Fetal bovine serum) and 36 mL of RPMI to create complete Roswell Park 
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Memorial Institute (cRPMI) medium with 10% FBS into each conical tube.  Twenty (20) 
mL of the cells and medium was added to each T175 Flask (Corning, NY, USA) and 
incubated in a CO2 incubator for 2 hours and 30 minutes at 37˚C. 
Monocyte Isolation Using Plastic Adherence Technique 
 Monocytes were isolated using a modified version of the plastic adhesion method 
(Rajput, 2014).  After the 2-1/2 hour incubation, the floating cells were removed from the 
flasks by decanting the media, removing by pipetting any additional media in the flasks 
and then discarded.  Two-hundred and fifty (250) mL of warm PBS was poured into each 
flask at 50 mL intervals for a total of 5 washes.  Each wash consisted of rocking the flask 
back and forth for 1 minute and then the liquid was disposed of.  After a flask had been 
washed, 6 mL of Accutase™ (eBioscience, San Diego, CA, USA) was added to the flask 
and the flask was incubated in a CO2 incubator for 10 minutes at 37˚C.  When incubation 
was finished, the detached cells were washed and pelleted through centrifugation at 
120xg for 10 minutes at room temperature.  The pellet was resuspended and washed and 
pelleted a second time.  Before culturing the monocytes into MDDCs, the cells were 
verified to be monocytes using the phenotypic markers MHCI, MHCII, and DC86. 
Monocyte-Derived Dendritic Cell (MDDC) Culture 
 MDDCs were cultured following the protocol in Rajput, 2014 with procedural 
modifications.  RPMI 1640  medium (GE Healthcare, Hyclone Laboratories, Logan, UT, 
USA) supplemented with penicillin (100 U/mL) and streptomycin (100 μg/mL) was 
added.  Twenty mL (4 mL of FBS and 16 mL of RPMI; final concentration of 20% FBS) 
were added to the monocytes.  Additionally, 1 mL of IL-4 (10 μg/mL) and 100 μL of 
GM-CSF (10 μg/mL) were added to the 20 mL mixture.  Two, 6-well plates were used 
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for the MDDC growth.  Into each well, ~3 mL of cell mixture were added.  The two 
plates were placed into a CO2 incubator at 37˚C on a plate shaker for 12 hours.  After 12 
hours, the plates were removed from the shakers and allowed to grow for 4 days and 12 
hours longer.  Every other day, each well containing cells was feed with 1 mL of RPMI 
1640 medium containing 20% FBS, IL-4, and GM-CSF.  After the 5 days of growth, the 
DCs were examined for surface markers and virally infected. 
Monocyte-Derived Dendritic Cell (MDDC) Surface Marker Expression 
 Before the DCs were infected with virus, the DCs were characterized 
phenotypically as MHC1, MHCI positive, and CD14 low using the Rajput, 2014 
technique.  The DCs were first split into a 96-well plate at a 1x10
5
 concentration per well.  
The DCs were then washed with PBS by centrifugation for 10 minutes at 120xg.  The 
DCs were labeled using the primary mouse monoclonal antibodies (mAbs) MHCI 
(H58A), MHCII (H42A), and CD14 (CAM36A) (Monoclonal Antibody Center, WSU, 
Pullman, WA, USA).  MHCI, MHCII, and CD14 antibodies were diluted 1:100 in PBS.  
Controls of DCs not treated with antibodies and not treated with secondary antibodies 
were used.  Additionally, 1% FBS was added to each diluted primary antibody.  For each 
of the three antibodies, 50 μL of the diluted primary antibodies were added to the DCs 
and incubated for 10 min at 4°C followed by washing with PBS.  Following the wash, the 
DCs were stained with 50 μL of a 1:1000 diluted in PBS fluorescein isothiocyanate 
(FITC) labeled anti-mouse secondary antibody (VMRD Inc., Pullman, WA, USA) 
containing 1% FBS for 10 minutes at 4°C.  Following the secondary antibody staining, 
the DCs were resuspended in 200 μL of 1% paraformaldehyde.  Finally, the DCs were 
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analyzed for surface marker expression using a BD Accuri™ C6 Plus Flow Cytometer 
(BD Biosciences, CA, USA).  
Viral Growth and Titration 
 For each virus, 5 mL of 5x10
5
 MDBK cells/mL were grown in 5 T25 flasks.  The 
cells were grown to around 60-70% confluency.  At inoculation, the RPMI growth media 
was removed and 0.75 mL of the specific BVDV virus was added to each flask using an 
MOI of 1.  The cells were incubated for 1h at 37°C.  After incubation, the virus was 
removed and the cells were washed using sterile PBS.  After washing, 5 mL of RPMI was 
added to each flask and then incubated for 4 days at 37°C.  The cultures were harvested 
using two freeze thaw cycles.  The freeze thaw cycles consisted of -80°C exposure for 15 
minutes and then thawed using 25°C.  The cell debris was pelleted using centrifugation at 
1200xg for 10 minutes at 4°C.  The supernatant containing the virus was then titrated at 
1x10
5
 and stored at -80°C. 
 Viral titration was done using the method developed by Reed and Muench (Reed 
and Muench, 1938).  MDBK cells were grown prior, detached, and adjusted to 5x10
5
 
cells/mL.  One hundred-eighty (180) μL, of the MDBK cell suspension, was added to 
each well in a 96-well plate.  Twenty (20) μL of virus stock was added to the first row, 
mixed, and then 20 μL was taken out from each well and added to the well below.  This 
process was repeated until the bottom 2 rows as they were used for negative control.  
Four replications were used for each dilution.  The plate was incubated at 37°C for 4 
days.  An immunoperoxidase (horseradish peroxidase, HRP) assay was conducted to 
determine the endpoint to calculate virus titer (Fulton et al., 1997) using the BVDV E2 
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Mab 15C5.  The endpoint was determined by cellular red precipitate formed by HRP 
labeled BVDV antibody causing a reaction with the HRP substrate 3-amino-9-
ethylcarbazole indicating the presence of BVDV protein. 
Viral Infection 
 MDDCs were infected with one of 2 different BVDV strains, 1373 or 28508.  The 
viral strains were diluted from the original titration to a multiplicity of infection (MOI) of 
1 using RPMI 1640 medium.  After an incubation period of 5 days, the MDDCs were 
washed with PBS to remove old media and resuspended in RPMI 1640 medium with 
1x10
6
 MDDCs per mL.  A 48-well plate was used for the viral infection with 100 μL of 
MDDCs and 100 μL of diluted virus added to each infected well.  In the control wells, 
100 μL of MDDCs were added and 100 μL of RPMI 1640 medium was used instead of 
virus.  BVDV strains 1373, 20508, and the control were all done in triplicates for each 
time point.  After infection, incubation was done at 37°C.  Cells were collected at 0 
hours, 6 hours, 12 hours, 24 hours, and 48 hours for a total of 9 wells for each strain and 
control.  Cells were collected at each time point by removing the supernatant and then 
centrifuging each sample at 120xg for 10 minutes.  The supernatant was then removed 
and frozen at -80°C, and 100 μL of PBS was added to the pellet.  The pellet was 
resuspended and was used for qRT-PCR. 
Quantitative Reverse Transcriptase Polymerase Chain Reaction 
 The BVDV infected cells, noninfected cells (cell control), and DNase RNase free 
water (negative control) (Invitrogen, Life Technologies, Thermo Fisher Scientific, PA, 
USA) had nucleic acid extracted using a RNeasy extraction kit (Qiagen, Valencia, CA, 
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USA).  The extracted nucleic acid from the infected cells and noninfected cells were 
normalized using the lowest ng/μL which was determined using Nanodrop ND-2000 
Spectrophotometer (Fisher Scientific, NH, USA).  Next, qRT-PCR was conducted for 
expression of the following cytokines: IFN-alpha, IFN-beta, IFN-gamma, IL-1a, IL-1b, 
IL-6, IL-8, IL-10, IL-12, and TNF.  Beta-actin was used for the housekeeping gene to 
ensure PCR efficiency and standardization.  The primers used are included in table 2.1.  
For qRT-PCR, reaction sizes of 25 μL were used in each well of a standard 96-well PCR 
plate.  For qRT-PCR, a Power SYBR® Green RNA-to-Ct™ 1-Step Kit was used for the 
master mix (Thermo Fisher Scientific, PA, USA).  For the tested samples 2 μL of the 
normalized samples, DNase RNase free water, for the negative control, and LPS for the 
positive control were used.  The quantification of the cellular mRNA was conducted 
using an ABI 7900HT High-Throughput Real-Time Thermocycler (Applied Biosystems, 
Life Technologies, Thermo Fisher Scientific, PA, USA).  Results from the qRT-PCR 
were given in cycle threshold (CT) values.  The CT value refers to the number of PCR 
cycles before threshold detection is found.  The CT values were analyzed using the 
relative expression software tool (REST©2009 software) (Pfaffl et al., 2002). 
Statistical Analysis 
 Data was analyzed using a student's t-test to determine the significance of the 
differences between the mean values of the treated samples and the control samples at the 
time points.  A statistical significance was seen at a P-value <0.5 and a biological 
significance was seen at a P-value <0.1 but >0.5.  All of the experiments were conducted 
using at least 3 animals, breed depended on the experiment, and 3 repeats for each 
animal.  Standard deviation was used for each time point.  The cytokine analysis was 
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based on the analysis of variance (ANOVA) using the REST© 2009 program (Pfaffl et 
al., 2002). 
 
RESULTS 
Monocyte-Derived Dendritic Cell Technique Optimization 
 Prior to these optimization experiments the yield of MDDCs (MHCI
+
, MHCII
+
, 
CD86
+
, CD14
low
) was ~ 1x10
4
 MDDCs per well in a 48-well plate.  After the protocol 
optimization, the MDDCs increased 10-fold to 1x10
5
 per well in a 48-well plate.  A 
number of adjustments were made to the starting protocol to increase yield.  The first 
change made from the original protocol was using SepMate™ tubes instead of normal 
conical tubes.  The total amount of buffy coat collected increased by about 40% using the 
SepMate™ tubes as opposed to the conical tubes from the original protocol.  Before the 
yield increased, the SepMate™ tubes were optimized with various volume ratios of blood 
and lymphoprep.  With the centrifuge speed, 1200xg, used by Rajput, et al., 15 mL of 
lymphoprep and 20 mL of blood was the optimal ratio.  Another problem that caused 
repeated trials to optimize yield was the large number of platelets with the PBMC.  
Centrifuge speeds were tested starting at 80xg to 160xg.  The speed of 120xg was the 
optimal speed to separate platelets in the conical tubes from the pellets.  This decreased 
the number of washes needed by 1 or 2 depending on the starting platelet count.  The 
number of cells lost during each washing step was small, around 10%, and the total 
number of cells retained increased.  Originally, 6-well plates were used for attachment 
separation but was switched to T175 flasks.  When using the 6-well plates, yield was 
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1.5x10
5
 MDDCs per mL, but when flasks were used the yield of MDDCs averaged about 
3.5x10
5
, >200% increase.  Originally, the attachment incubation time was 3 hours.  When 
decreased to 2 hours and 30 minutes of incubation time, the monocytes were easily 
detachable.  A checkerboard was done to determine the optimal amount of IL-4 and GM-
CSF.  An increase of 0-150% was found depending on the combinations of these two 
cytokines.  The best combination increased the number of MDDCs from 3.5x10
5
 per mL 
to around 5x10
5
 MDDCs per mL with the previous optimization steps included in the 
MDDC totals.  Shaking the cells during the first 12 hours of monocyte differentiation 
increased the number of MDDCs from 5x10
5
 per mL to around 1x10
6
-1.2x10
6
 per mL.  
Brown Swiss cattle have a higher number of monocytes resulting in a higher number of 
MDDCs than Holstein Friesian.  On average, a Brown Swiss would yield about 1x10
5
-
2x10
5
 more MDDCs per mL than a Holstein Friesian.  A summary can be found in table 
2.2. 
BVDV Infected MDDC Cytokine Expression 
 MDDC cytokine expression was analyzed for IFN-alpha, IFN-beta, IFN-gamma, 
IL-1b, IL-1b, IL-6, IL-8, IL-10, IL-12 and TNF.  Each of the IFN cytokines were similar 
to each other, all being under a 2-fold increase (Figs 2.1, 2.4, and 2.5).  The IL cytokines 
were broken into two groupings.  First, IL-1b had > 40-fold decrease (Fig 2.7).  Second, 
the remainder of the IL cytokines had a 5-10-fold decrease (Figs 2.6, 2.8, 2.9, 2.12, and 
2.13).  Finally, TNF had a 2-7-fold decrease (Fig 2.14).  Only IFN-alpha and IL-8 
showed statistical significance between the strains with a p-value <0.05, while the other 8 
cytokines mRNA had neither statistical significance nor biological significance 
(biological significance is, a p-value between >0.05 and <0.1).  While there was 
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statistical significance between 1373 and 28508 for IFN-alpha, the down regulation was 
small and likely would not have a large biological effect.  IFN-alpha was down regulated 
in 1373-infected MDDCs at every time point after infection.  Only at the 48h time point 
was IFN-alpha down regulated by 28508 (Fig 2.1).  When analyzed by breed, IFN-alpha 
was down regulated by 1373 -0.6±0.0-fold for Brown Swiss at 6h compared to                  
-1.1±0.1-fold for Holstein Friesian.  At 12h p.i., the IFN-alpha levels for the Brown Swiss 
was at -1.0±0.1-fold compared to the Holstein Friesian at -1.9±0.0-fold.  At 24h p.i., IFN-
alpha for the Brown Swiss was down regulated -1.6±0.1-fold and the Holstein Friesian 
was down regulated -2.2±0.1-fold.  At the final time point of 48h, the IFN-alpha down 
regulation was -1.4±0.0-fold for the Brown Swiss compared to -1.7±0.0-fold for the 
Holstein Friesian.  For IFN-alpha with 28508, only the Holstein Friesian calves had down 
regulation with a value of -1.0±0.0-fold at the 48h time point.  A cattle breed comparison 
for IFN-alpha was done for the 1373 (Fig 2.2) and 28508 (Fig 2.3) strains.  IFN-beta 
decreased in 1373-infected MDDCs from 6h to 48h and 24h to 48h for 28508.  The 
largest decrease was at -1.3-fold for 1373 and -0.4-fold for 28508 (Fig 2.4).  No cytokine 
expression was seen until 12 hours for 1373 and 24 hours for 28508 with IFN-gamma.  
The largest decrease was seen for 1373 at -0.3-fold at 24h and -0.2-fold at 48h (Fig 2.5).  
No cytokine expression was seen until 6h for IL-1a.  Both viruses had the largest 
decrease at 48h with 1373 at -8.5-fold and 28508 at -6.9-fold (Fig 2.6).  No cytokine 
expression was seen until 6h for IL-1b.  Both viruses had the largest decrease at 24h with 
1373 at -46.1-fold and 28508 at -44.7-fold.  A large difference was seen at the 48h time 
point (Fig 2.7).  No cytokine expression was seen until 6h for IL-6 for both viruses.  For 
1373-infected MDDCs, had the largest decrease of -6.4-fold and -3.4-fold for 28508 at 
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6h.  The cytokine expression varied at the other time points (Fig 2.8).  At the 6h time 
point, 1373 down regulated IL-8 -3.9±0.5-fold while 28508 down regulated IL-8              
-1.4±0.2-fold (Fig 2.9).  For the 12h time points, 1373 down regulated -5.6±0.5-fold and 
28508 was -2.2±0.2-fold.  At 24h, IL-8  was down regulated by 1373 -7.9±1.2-fold and 
28508 was decreased -4.3±0.6-fold.  At the 48h time point, the down regulation 
decreased, with 1373 at -6.8±1.1-fold and 28508 at -5.6±1.0-fold.  A comparison of the 
two cattle breeds expression of IL-8 for 1373 (Fig 2.10) and 28508 (Fig 2.11) was also 
done.  At 6h p.i., the IL-8 expression in Brown Swiss calves was down regulated -3.4-
fold while the Holstein Friesian was down regulated -4.4-fold.  At 12h p.i., the IL-8 
mRNA in Brown Swiss MDDC averaged -5.4-fold down regulation while Holstein 
Friesian averaged -5.9-fold down regulation.  The largest down regulation  for IL-8 was 
seen at 24h p.i., with Brown Swiss averaging -7.4-fold and Holstein Friesian at -8.4-fold.  
Down regulation of IL-8 decreased at 48h p.i. with an average of -6.1-fold for Brown 
Swiss and -7.6-fold for Holstein Friesian.  For IL-10 expression was first seen at 6h for 
both viruses.  The greatest decrease for 1373 was seen at 24h with -6.9-fold and the 
greatest decrease for 28508 at 48h with -5.5-fold.  A decrease started after 24h for 1373 
(Fig 2.12).  Expression was first seen at 6h for IL-12.  A peak was seen at 24h with -9.2-
fold for 1373 and 48h with -6.7-fold for 28508.  A decrease started after 24 for 1373 (Fig 
2.13).  Finally, for TNF peaks were seen at 48h for 1373 at -6.5-fold and 28508 at -4.5-
fold.  The 24h time point for 1373 was higher than the peak of 28508 (Fig 2.14). 
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DISCUSSION 
Monocyte-Derived Dendritic Cell Technique Optimization 
 The MDDC protocol that was developed by Rajput, 2013 was further optimized 
to increase MDDC yield.  When first starting the experiments and culturing MDDCs, 
about 500 mL of blood was collected from each calf.  Using less blood gave too little 
MDDCs to work with.  This amount of blood took a large amount of resources and time 
to isolate monocytes and culture them into MDDCs.  While the original procedure 
worked, a less expensive and less time consuming process was developed.  SepMate™ 
tubes made a large difference in obtaining the buffy coat.  The original way of layering 
blood without the insert that is in a SepMate™ tube caused problems in either obtaining 
all of the buffy coat to avoid collecting any RBCs or RBCs would be collected in the 
attempt to collect as much buffy coat as possible.  With the insert in the SepMate™ tubes 
the RBCs that can cause problems in buffy coat collection are trapped underneath the 
insert.  This made the chance of contaminating the buffy coat with RBCs less likely and 
also decreased the time required for removing the buffy coat.  With the addition of using 
SepMate™ tubes the problem of centrifugation speed had to optimized with them.  The 
speed of 1200xg was found to be ideal as the speed prevented any buffy coat from going 
beneath the insert and any RBCs to come above the insert.  Before finding the optimal 
speed for the amount of blood and lymphoprep used in each SepMate™ tube, the tubes 
actually proved to be worse.  In the case of centrifugation at higher speeds, more buffy 
coat was usually lost under the insert than would have been lost using the original 
separation method.  After starting with a speed that was too high, the speed was reduced 
to 800xg and increased in increments of 100xg.  Using a spin time of 20 minutes for the 
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entire time period of allowed for an easy way to keep testing the speed until all of the 
RBCs went underneath the insert while leaving the buffy coat on top.  Finding the 
optimal speed for the blood separation increased the number of MDDCs at the end by 
4x10
4
.  The other time the centrifuge speed was optimized was when attempting to wash 
the pellet and remove as many platelets as possible.  Supernatant above the insert was 
poured off, an excess number of platelets had to removed.  The goal was to do as few 
washes a possible, while removing the platelets.  At a speed of 120xg, the PBMCs were 
able to pellet while retaining very few platelets after removing the supernatant.    
Spinning any faster than 120xg saw a drastic increase in platelets that were part of the 
pellet.  This required more washes, which caused the loss of MDDCs with each 
additional wash.  Next, the separation of monocytes from the rest of the cells found in the 
pellet was optimized.  Originally 6 well plates were used, but the surface area wasn't 
large enough and many monocytes were washed off after the incubation period because 
they didn't stick to the plastic.  Using cell culture flasks rather than 6-well plates, resulted 
in more viable cells to grow in a large, single layered sheet than in smaller wells.  With 
the 6-well plates, the cells would attach to the sides or more frequently adhere to each 
other.  In both cases the cells were usually lost when washing after incubation.  Using a 
flask eliminated this problem; a specific number of cells was added to each flask to allow 
the formation of a monolayer of cells during the incubation.  An increase of 2x10
5
 cells 
was seen from the original protocol by using a flask.  Trying to find the optimal ratio of 
IL-4 and GM-CSF proved to be the most challenging part of the optimization phase.  
Interestingly enough, nearly every ratio that was tried had monocytes differentiate into 
MDDCs just at different amounts.  Using no GM-CSF, but only IL-4 produced MDDCs 
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in a rather low number.  This was seen even with low concentrations of IL-4.  When 
using just GM-CSF, no MDDCs were observed regardless of how much GM-CSF was 
used.  Using equal ratios of both cytokines produced more MDDCs than using only one.  
After showing that both cytokines were needed, the ratios of both cytokines were 
increased or decreased.  A 10:1 ratio of IL-4 to GM-CSF produced the highest numbers 
of MDDCs.  Around 1.5x10
5
 more MDDCs were produced when using 100 μL IL-4 (10 
μg/mL) and 10 μL of GM-CSF (10 μg/mL).  The biggest improvement to the MDDC 
yield came through the use of a cell shaker.  A major problem that was encountered when 
differentiating monocytes into MDDCs was the monocytes would settle at the bottom of 
the wells even after adding cytokines.  When the monocytes attached to the wells, they 
would differentiate into macrophages instead of MDDCs.  This problem was remedied by 
using a cell shaker on low during the first 12 hours of MDDC growth.  The cell shaker 
caused a majority of the monocytes that weren't differentiating to remain unattached, 
increasing the MDDCs yield to 5x10
5
. At first 24 hours was used, but more macrophages 
were seen after 24 hours than 12 hours.  This can be explained by the monocytes being 
stimulated due to aggravation, which caused the monocytes to differentiate into 
macrophages instead of MDDCs.  At 12 hours, macrophages were seen in small 
quantities.  Finally, cow breed plays an important role in the number of monocytes.  The 
breed difference between Brown Swiss and Holstein Friesian differed largely by the 
number of circulating monocytes.  The Brown Swiss calves had between 1x10
5
 - 2x10
5
 
more MDDCs after growth than the Holstein Friesians.  While it was to be expected that 
a different breed of cattle would have some differences in immune cells, the large 
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difference in the two breeds studied provided the Brown Swiss an ideal breed to use for 
future studies of MDDCs.  
BVDV Infected MDDC Cytokine Expression 
 For IL-1b, down regulation was seen starting at 6h for both viruses.  A large 
decrease was seen between the control for both viruses and between both viruses at 48h.  
At 48h a decrease in cytokine expression was seen for 1373 and 28508.  This coincides 
with a study conducted in mice where IL-1b was down regulated with the neuroadapted 
Sindbis virus (NSV) (Liang et al., 1998), but differs in a study on HCV infected 
macrophages in humans (Shrivastava et al., 2013).  In the study (Liang et al., 1998) 
conducted with mice, a lack or decrease in IL-1b provides protection against NSV-
induced disease but not infection.  A decrease in IL-1b could help in decreasing innate 
immunity against BVDV which would aid in immunosuppression and increase in 
bacterial secondary infections as IL-8 is a neutrophil chemotaxic factor.  In HCV 
infections, induction of IL-1b synthesis occurs by the NF-kB signaling pathway.  The 
secretion then occurs by HCV contacting the macrophages (Shrivastava et al., 2013).  
The IL-1b cytokine down regulation in MDDCs is consistent with the Shrivastava study 
as macrophages will want up regulation, but DCs won't because of the increased mobility 
issues inflammation causes for DCs in vivo.  In another study, IL-1b and IL-8 mRNA 
were up regulated in MDBK cells using a low virulence cytopathic BVDV-1  type 1b 
strain (Fredericksen et al., 2015).  Epithelial cells like MDBK do not produce IL-8.  IFN-
alpha is involved in inflammation with the down regulation of IFN-alpha BVDV by 
strain 1373 likely  decreasing the inflammation process.  It is well established in vitro that 
ncp BVDV evades the host's IFN defense in a complex way: (i) it avoids induction of 
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IFN, (ii) once infection is established, the virus ("self") is resistant to the action of IFN 
and (iii), it does not interfere with IFN action against unrelated viruses ("nonself") 
replicating in the same host cells (Peterhans, 2013).  There is additional data that 
interferon is measured in the serum 3-5 days post ncp BVDV infection (Reid et al., 
2016).  A study conducted with either ncp or cp BVDV obtained from PI animals with an 
enriched population of plasmacytoid dendritic cells (pDCs) from lymph nodes induce 
type III IFNs and low levels of type I IFNs like IFN-alpha (Reid et al., 2016).  Although, 
pDCs were not the cell type used in the current study.  This study also infected animals 
with the same viruses and demonstrated that all of the serum IFN was acid labile, which 
indicated that it was not type 1 IFN (IFN-alpha or IFN-beta) consistent with the results 
from our study (Reid et al., 2016).  In MDDCs infected by 28508, no change in cytokine 
was seen until the 48h time points.  Yet by the time 1373 had reached 48h p.i., the 
MDDCs were only shown to have down regulation equal to the 6h time point for 1373.  
Additionally, the Holstein Friesian calves were down regulated while Brown Swiss 
calves had no down regulation.  With the results obtained, breed seems to play an 
important role in how easily MDDCs are infected.  With IFN-beta, 1373 infection 
resulted in significant decrease compared to both the control and 28508. On the other 
hand, 28508 had no significant difference from the control.  With IFN-gamma, a small 
difference was observed between viruses and control.  A decrease in expression started 
after 24h for 1373.  For  IL-1a, the decrease was less than IL-b by a large amount.  The 
largest down regulation was seen in 1373 for all time points.  For IL-6, there was a 
significant decrease between the two viruses at the 6h and 24h time points.  The cytokine 
expression was odd as a pattern like the other cytokines was not seen, with 1373 
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increasing and decreasing and 28508 decreasing until 24h then increasing after.  Because 
of the immune suppression and secondary bacterial infection associated with BVDV, 
down regulation was expected for IL-8 due to its importance in chemotaxis to attract 
neutrophils.  Down regulation was more prominent in 1373 infected MDDCs, the higher 
virulence strain than 28508, the lower virulence strain.  Both strains had an increase in 
cytokine down regulation up until the 24h time point.  Interestingly, the 48h time point 
for 1373 infected MDDCs saw a decrease in the down regulation.  This can be explained 
by the loss of MDDCs by the 48h time point.  With 28508 this decrease was not seen at 
the 48h time point, but rather saw a continual down regulation of cytokine expression.  It 
is likely that enough cells would die after 28508 infection that a decrease in down 
regulation would be seen.  Cattle breed played a more important role than originally 
expected in cytokine expression.  At all time points with both viruses, Brown Swiss had 
less down regulation than Holstein Friesian.  This indicates, at least in the case of 
MDDCs, Brown Swiss have a higher quality of MDDCs that are not as easily infected.  
Also, the possibility of an overall better immune system that fights off the viruses to 
prevent more infection is a plausible conclusion.  Both IL-10 and IL-12 were similar in 
the cytokine expression, but IL-12 had more down regulation.  Both cytokines had 
significant decreases at 6h, peaked at 24h for 1373 and 48h for 28508, and decreased 
after the 24h time point for 1373.  Another BVDV study in 1373 infected calves showed 
that pro-inflammatory (TNF, IL-1b, IFN-gamma, and IL-12) and anti-inflammatory (IL-
10) were up regulated in lymph nodes cells, i.e. B and T cells (Palomares et al., 2014).  
Finally, TNF was down regulated at similar levels as the non-IL-1 cytokines.  Strain 1373 
infected MDDCs down regulated TNF-alpha more than 28508, with the 24h time point of 
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1373 being higher than the 48h time point for 28508.  These TNF results correlate with a 
study on ncp infected monocytes.  Both BVDV-1 and BVDV-2 down regulated TNF 
compared to the control (Seong et al., 2013).  For the majority of the cytokines, cytokine 
expression increased or decreased the most at the later time periods.  Depending on the 
cytokine, the highest reductions were at the 24h or 48h time points with the exception of 
IL-6 that had the highest reduction at the 6h time point. 
Summary 
 The greatest impact to improve MDDC yield came from shaking the monocytes 
for 12 hours at the start of incubation.  This prevented the monocytes from sticking to the 
plates and becoming macrophages instead.  The breed of calf indicated that there was a 
difference in MDDC yield.  This was because monocytes were found at a higher level in 
the blood for Brown Swiss calves than for Holstein Friesian calves.  IL-1b had the 
greatest down regulation of more than 40-fold.  The IFN cytokines all had less than        
2-fold decrease.  The remainder of the IL cytokines and TNF had less than 10-fold 
decrease.  Down regulation was higher for 1373 than 28508. 
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Fig 2.1. BVDV IFN-Alpha down regulation: BVDV 1373 and 28508 strains IFN-Alpha 
down regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.2. BVDV strain 1373 IFN-Alpha down regulation: BVDV 1373 strain IFN-
Alpha down regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.3. BVDV strain 28508 IL-8 down regulation: BVDV 28508 strain IFN-Alpha 
down regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.4. BVDV IFN-Beta down regulation: BVDV 1373 and 28508 strains IFN-Beta 
down regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.5. BVDV IFN-Gamma down regulation: BVDV 1373 and 28508 strains IFN-
Gamma down regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.6. BVDV IL-1a down regulation: BVDV 1373 and 28508 strains IL-1a down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.7. BVDV IL-1b down regulation: BVDV 1373 and 28508 strains IL-1b down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.8. BVDV IL-6 down regulation: BVDV 1373 and 28508 strains IL-6 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.9. BVDV IL-8 down regulation: BVDV 1373 and 28508 strains IL-8 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.10. BVDV strain 1373 IL-8 down regulation: BVDV 1373 strain IL-8 down 
regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.11. BVDV strain 28508 IL-8 down regulation: BVDV 28508 strain IL-8 down 
regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.12. BVDV IL-10 down regulation: BVDV 1373 and 28508 strains IL-10 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 2.13. BVDV IL-12 down regulation: BVDV 1373 and 28508 strains IL-12 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 2.14. BVDV TNF down regulation: BVDV 1373 and 28508 strains TNF down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Cytokine Forward Primer 5'-3' Reverse Primer 5'-3' 
Beta-Actin 
CGC ACC ACT GGC 
ATT GTC AT 
TCC AAG GCG ACG 
TAG CAG AG 
IFN-Gamma 
CAG ATC ATC CAC C 
GGA ATT TGA ATC 
AGC 
IL-1a 
GAT GCC TGA GAC 
ACC CAA 
GAA AGT CAG TGA 
TCG AGG G 
IL-1b 
CAA GGA GAG GAA 
AGA GAC A 
TGA GAA GTG CTG 
ATG TAC CA 
IL-6 
TCC AGA ACG AGT 
ATG AGG 
CAT CCG AAT AGC 
TCT CAG 
IL-8 
AAT GGA AAC GAG 
GTC 
TGC TTA AAC CCC 
AAG 
IL-10 
TGC TGG ATG ACT 
TTA AGG G 
AGG GCA GAA AGC 
GAT GAC A 
IL-12 
AAC CTG CAA CTG 
AGA CCA TT 
ATC CTT GTG GCA 
TGT GAC TT 
TNF 
AGC CCA CGT TGT A 
GCC GAC ATC AAC 
TCC 
Table 2.1 Primer Summary: The primers used in qRT-PCR. 
Optimization Technique MDDC % Increase MDDCs per mL 
Original Protocol N/A 1x10
5
 
SepMate™ Tubes  40% 4x10
4
 
Centrifuge Speed 10% 1x10
4
 
Plate Adhesion 200% 2x10
5
 
Optimal Cytokine Amounts 150% 1.5x10
5
 
Cell Shaker 500% 5x10
5
 
Cow Breed 100%-200% 1x10
5
 - 2x10
5
 
Total 900% 1x10
6
 
Table 2.2. Summary of MDDC Optimization Techniques: The techniques that were 
used in optimization with the effect on MDDCs yield is summarized.  Cattle breed wasn't 
factored into the total increase. 
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CHAPTER 3: BOVINE HERPESVIRUS TYPE 1 CYTOKINE AND SURFACE 
MARKER ANALYSIS 
ABSTRACT 
 Bovine herpesvirus type 1 (BHV-1) is an important virus in the cattle industry 
that leads to a variety of important symptoms.  It is important to develop a better 
understanding of BHV-1 and the effect it plays on dendritic cells to better understand the 
relationship between the innate and adaptive immune systems.  Dendritic cells are the 
main antigen presenting cells that serve to link the two immune systems together.  A 
dendritic cell will present an antigen to a naive T cell and cause activation into a mature 
T cell.  A virally infected dendritic cell may cause problems between the innate and 
adaptive immune system link by having an adverse effect on the antigen presenting 
response dendritic cells have.  BHV-1 was used in this study and the effects the virus had 
on dendritic cell cytokine production and surface marker expression were observed.  
Monocytes were collected from calf blood and differentiated into monocyte-derived 
dendritic cells.  This was done over a 5-day time period using IL-4 and GM-CSF.  The 
monocyte-derived dendritic cells were then infected with the Cooper strain or the LA 
strain, two BHV-1 strains.  Five (5) of the 8 measured cytokines expressed by BHV-1 
infected monocyte-derived dendritic cells were down regulated.  The IFN family, IFN-
alpha, IFN-beta, and IFN-gamma were up regulated.  IFN-alpha had a more than a 10-
fold increase, IFN-beta had a more than a 3-fold increase, and IFN-gamma had less than 
a 1-fold increase.  The other 5 IL cytokines were down regulated with less than a 4-fold 
decrease.  The Cooper strain significantly down regulated cytokine IL-1b, IL-6, IL-8, IL-
10, and IL-12 mRNAs more than the LA strain compared to the control.  The Cooper 
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strain significantly up regulated IFN-alpha, IFN-beta, and IFN-gamma mRNA.  The 
cytokine fold differences between Cooper and LA strains, were: 0.25 for IL-1b, 0.25 for 
IL-6, 0.25 for IL-8, 0.50 for IL-10, 0.10 for IL-12, 5 for IFN-alpha, 0.5 for IFN-beta, and 
0.25 for IFN-gamma.  Statistically significant differences between the Cooper and LA 
strains were only seen for IL-8 and IFN-alpha.  Surface marker expression was also 
observed following BHV-1 infection of MDDC.  From the first time point observed, 6h, 
to the last time point observed, 48h, mean fluorescence intensity decreased in MHCI, 
MHCII, and CD86.  This was seen primarily in the Cooper strain infected MDDCs, but 
CD86 also decreased with the LA strain.  No change was seen in CD14 due to the very 
low amount of CD14.  Both Cooper and LA strains interfered with normal MDDC 
cytokine and surface marker expression. 
 
INTRODUCTION 
 Bovine herpesvirus type 1 (BHV-1) is a major viral pathogen that infects cattle 
and causes symptoms such as: abortion, conjunctivitis, genital infections, and respiratory 
disease (Jones, 2003, Tikoo et al., 1995).  Bovine respiratory disease, which BHV-1 is a 
contributing factor, is also known as shipping fever and plays an important role in large 
financial loses each year in the cattle industry.  BHV-1 infections can cause 
immunosuppression and increase the possibility of secondary bacterial infections (Biswas 
et al., 2013, Jones, 2003).  BHV-1 symptoms depend on the subtype of the virus.  
Respiratory diseases arise from BHV-1.1.  BHV-1.2 results in genital infections.  Both 
substrains can cause abortions (Biswas et al., 2013). 
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 BHV-1 is able to gain access to the host through the conjunctiva, the mucosa of 
the upper respiratory tract, or the reproductive tract.  BHV-1 destroys the epithelium 
layer and enters the blood to cause viremia.  Through viremia, the virus is able to spread 
to additional organs of the body, specifically the central nervous system and the 
reproductive system (Straub, 1990; Renjifo et al., 1999).  Symptoms are observed around 
the fourth day of post infection and generally last no more than ten days.  Having an 
infected animal in the heard is problematic due to the ease of the spread of BHV-1 and 
the animal should be monitored closely (Biswas et al., 2013).  Two BHV-1 strains, 
Cooper (Colorado) and LA, were isolated from severe respiratory disease outbreaks in 
Colorado and California in the 1950's (Madin, 1956). 
 This study was designed to determine the effect of BHV-1 on MDDC cytokine 
mRNA and surface marker expression through in vitro studies.  The susceptibility of 
MDDCs to BHV-1 strains Cooper and LA were tested and the cytokine expression and 
surface marker expression was measured for both strains. 
 
MATERIALS AND METHODS 
Animals 
 Healthy calves between the ages of 6-8 months housed at the South Dakota State 
University (SDSU) Dairy Farm located in Brookings, SD, USA were used as blood 
donors in this study. Three Holstein Friesian calves were used. The SDSU Institutional 
Animal Care and Use Committee approved the handling of animals and blood collection. 
All of the calves were confirmed to be BVDV-free using virus isolation following a test 
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by immunoperoxidase assay (IPA) (Fulton et al., 1997). Blood (~ 250 ml per draw) was 
collected via jugular venipuncture using 60 ml heparinized plastic syringes with 16 gauge 
1-1/2 needles. 
Peripheral Blood Mononuclear Cell Isolation 
 Peripheral blood mononuclear cells (PBMC) were isolated, cultured and 
characterized as described in the Materials and Methods Section "Peripheral Blood 
Mononuclear Cell Isolation" in Chapter 2. 
Monocyte Isolation Using Plastic Adherence Technique 
 Monocytes were isolated and characterized as described in the Materials and 
Methods Section "Monocyte Isolation Using Plastic Adherence Technique" in Chapter 2. 
Monocyte-Derived Dendritic Cell (MDDC) Culture 
 MDDCs were cultured as described in the Materials and Methods Section 
"Monocyte-Derived Dendritic Cell (MDDC) Culture" in Chapter 2. 
Monocyte-Derived Dendritic Cell (MDDC) Surface Marker Expression 
 Before the DCs were infected with virus, the DCs were characterized 
phenotypically as MHC1, MHCII, CD86 positive, and CD14 low using the Rajput, 2014 
technique as described in the Materials and Methods Section "Monocyte-Derived 
Dendritic Cell (MDDC) Surface Marker Expression" in Chapter 2. 
Viral Growth and Titration 
 For each virus, 5 mL of 5x10
5
 MDBK cells/mL were grown in 5 T25 flasks.  The 
culture was grown to around 60-70% confluency.  At inoculation, the RPMI growth 
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media was removed and 0.75 mL of the specified BHV-1 virus was added to each flask 
using an MOI of 1.  The cells were incubated for 1h at 37°C.  After incubation, the virus 
was removed, and the cells were washed using sterile PBS.  After washing, 5 mL of 
RPMI was added to each flask and then incubated for 4 days at 37°C.  The cultures were 
harvested using two freeze thaw cycles.  The freeze thaw cycles consisted of -80°C 
exposure for 15 minutes and then thawed at 25°C.  The cell debris was pelleted using 
centrifugation at 1200xg for 10 minutes at 4°C.  The supernatant containing the virus was 
then titrated at 1x10
5
 and stored at -80°C. 
 Viral titration was done using the method developed by Reed and Muench (Reed 
and Muench, 1938).  MDBK cells were grown prior, detached, and adjusted to 5x10
5
 
cells/mL.  One hundred-eighty (180) μL, of the MDBK cell suspension, was added to 
each well in a 96-well plate.  Twenty (20) μL of virus stock was added to the first row, 
mixed, and then 20 μL was taken out from each well and added to the well below.  This 
process was repeated until the bottom 2 rows as they were used for negative control.  
Four replications were used for each dilution.  The plate was incubated at 37°C for 4 
days.  The highest dilution showing a cytopathic effect was used as the end point for 
calculating the proportionate distance which was then used for determining the viral 
concentration (Reed and Muench, 1938). 
Viral Infection 
 MDDCs were infected with one of 2 different strains of BHV-1, Cooper or LA .  
The viral strains were diluted to a multiplicity of infection (MOI) of 1 by using RPMI 
1640 medium.  After an incubation period of 5 days, the MDDCs were washed with PBS 
to remove old media and resuspended in RPMI 1640 medium with 1x10
6
 MDDCs per 
55 
 
mL.  A 48-well plate was used for the viral infection with 100 μL of MDDCs and 100 μL 
of diluted virus added to each infected well.  In the control wells, 100 μL of MDDCs 
were added and 100 μL of RPMI 1640 medium was used instead of virus.  The Cooper 
strain, the LA strain, and the control were all done in triplicates for each time point.  
After infection, incubation was done at 37°C.  MDDCs were collected at 0 hours, 6 
hours, 12 hours, 24 hours, and 48 hours for a total of 9 wells for each strain and control.  
MDDC collection consisted of removing the supernatant and then centrifuging each 
sample at 120xg for 10 minutes.  The supernatant was then removed and frozen at -80°C.  
The pellet was resuspended in 100 uL of PBS and was used for analyzing surface marker 
expression or for qRT-PCR. 
Quantitative Reverse Transcriptase Polymerase Chain Reaction 
 Quantitative Reverse Transcriptase Polymerase Chain Reaction was conducted as 
described in the Materials and Methods Section "Quantitative Reverse Transcriptase 
Polymerase Chain Reaction" in Chapter 2. 
Monocyte-Derived Dendritic Cell (MDDC) Surface Marker Expression Following   
BHV-1 Infection 
 Before the DCs were infected with virus, the DCs were characterized 
phenotypically as MHC1, MHCII, CD86 positive and CD14 low using the Rajput, 2014 
technique.  The DCs were first split into a 96 well plate at a 1x10
5
 concentration per well.  
The DCs were then washed with PBS by centrifugation for 10 minutes at 120xg.  The 
DCs were labeled using the primary mouse monoclonal antibodies (mAbs) MHCI 
(H58A), MHCII (H42A), CD14 (CAM36A), and CD86 (ILA190A) (Monoclonal 
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Antibody Center, WSU, Pullman, WA, USA).  MHCI, MHCII, and CD14 antibodies 
were diluted 1:100 in PBS while CD86 was diluted 1:50 in PBS.  Controls of DCs not 
treated with antibodies and not treated with secondary antibodies were used.    
Additionally, 1% FBS was added to each diluted primary antibody.   For each of the four 
antibodies, 50 μL of the diluted primary antibodies were added to the DCs and incubated 
for 10 min at 4°C followed by washing with PBS.  Following the wash, the DCs were 
stained with 50 μL of a 1:1000 diluted in PBS fluorescein isothiocyanate (FITC) labeled 
anti-mouse secondary antibody (VMRD Inc., Pullman, WA, USA) containing 1% FBS 
for 10 minutes at 4°C.  Following the secondary antibody staining, the DCs were 
resuspended in 200 μL of 1% paraformaldehyde.  Finally, the DCs were analyzed for 
surface marker expression using a BD Accuri™ C6 Plus Flow Cytometer (BD 
Biosciences, CA, USA ). 
 Viral infection of MDDCs was examined for the Cooper or LA strains and a non-
infected control.  The same protocol as detailed in the above paragraph was used with a 
few additions.  Before the primary antibody labeling, MDDCs were infected with the 
Cooper strain, LA strain, or left non infected.  Viral infection was conducted using a MOI 
of 1 and MDDCs were infected for 6 hours, 12 hours, or 24 hours.  After each period of 
infection, the MDDCs were labeled and their surface markers were analyzed. 
Statistical Analysis 
 Data was analyzed using a student's t-test to determine the significance of the 
differences between the mean values of the treated samples and the control samples at the 
time points.  A statistical significance was seen at a P-value <0.5 and a biological 
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significance was seen at a P-value <0.1 but >0.5.  All of the experiments were conducted 
using at least 3 animals, breed depended on the experiment, and 3 repeats for each 
animal.  Standard deviation was used for each time point.  The cytokine analysis was 
based on the analysis of variance (AVOVA) using the REST© 2009 program. 
 
RESULTS 
TCID50 Assay 
 A TCID50 assay was done for both virally infected MDDC with the Cooper strain 
or LA strain (Fig 3.1 A) and a control with MDBK cells (Fig 3.1 B).  Both experiments 
were broken into measuring the lysate and supernatant.  Following BHV-1 infection of 
the virus control, MDBK cells, virus was present in the lysate and supernatant at the 6h 
time point.  Both the lysate and supernatant steadily increase in viral titer until the 48h 
time point when both viruses had the same viral titers for both lysate and supernatant.  
Following BHV-1 infection of MDDCs lysate, infectious virus was present in both the 
cell lysate and supernatant as early as 6h.  The viral titers was 6.5log10 was seen early on, 
but slightly increased to a peak of 8.5 for Cooper lysate and 7.8 for Cooper supernatant.  
Both supernatant and lysate peaked at 7 logs for the LA strain.  Compared to the control, 
MDBK cells, MDDCs had a lower virus growth curve and lower virus yields.  The viral 
growth curve for Cooper infected MDDCs was 3.5 logs less than Cooper infected MDBK 
cells.  The viral growth curve for LA infected MDDCs was 6.5 logs less than LA infected 
MDBK cells.  The viral yield for Cooper infected MDDCs was 1.5 logs less than Cooper 
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infected MDBK cells.  The viral yield for LA infected MDDCs was 3 logs less than LA 
infected MDBK cells. 
BHV-1 Infected MDDC Cytokine Expression 
 MDDC cytokine mRNA expression was analyzed for IFN-alpha, IFN-beta, IFN-
gamma, IL-1b, IL-6, IL-8, IL-10, and IL-12.  IFN-alpha had > 10-fold increase (Fig 3.2), 
IFN-beta had approximately a 3-fold increase (Fig 3.5), and IFN-gamma had 
approximately a 0.5-fold increase (Fig 3.6).  The IL cytokines all had a decrease of less 
than 4-fold (Fig 3.7-3.9, 3.12, and 3.13).  Only IFN-alpha and IL-8 had statistical 
significance, with a p-value <0.05, while the other 6 cytokines showed neither statistical 
significance nor biological significance (biological significance is a p-value between 
>0.05 and <0.1).  For the Cooper strain at the 6h time point, the data was not statistically 
significant.  The LA strain had an average of 4.0±0.1-fold increase in IFN-alpha mRNA 
expression.  At the 12h time point, both the Cooper strain and the LA strain were similar 
with the Cooper strain having 6.0±0.3-fold up regulation and the LA strain having 
6.0±0.2-fold up regulation.  At 24h, the Cooper strain increased to 10.0±0.5-fold up 
regulation while the LA strain remained at 6.0±0.2-fold.  The final time point at 48h with 
the Cooper strain had an increase of 12.0±0.5-fold while the LA strain slightly increased 
to 7.0±0.3-fold (Fig 3.2).  Calf #1 and #2 were similar up regulation for all 3 statistically 
significant time points (Fig 3.3).  Calves #1-3 were also similar up regulation for all 4 
time points (Fig 3.4).  IFN-beta had an increase for both the Cooper and the LA strains 
from 6h to 48h.  There was a 3.6-fold increase for the Cooper strain and 2.9-fold increase 
for the LA strain (Fig 3.5).  No IFN gamma cytokine expression was seen until 12 hours 
for the Cooper strain and 24 hours for the LA strain.  IFN gamma mRNA peaked for 
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Cooper strain at 0.5-fold increase at 48h and 0.3-fold increase for the LA strain at 48h 
(Fig 3.6).  Both viruses had peak mRNA levels for IL-1b at 48h with the Cooper strain at 
-2.9-fold and the LA strain at -2.6-fold (Fig 3.7).  No IL-6 cytokine expression was seen 
until 12h for Cooper.  The Cooper strain had the greatest IL-6 mRNA levels decrease of  
-2.5-fold at 48h and -2.3-fold for the LA strain (Fig 3.8).  IL-8 was down regulated by 
BHV-1 (Fig 3.9).  Both Cooper and LA strains down regulated IL-8 at the 6h time point 
with the Cooper strain having a slightly larger down regulatory effect.  There was a          
-1.0±0.0-fold decrease in IL-8 mRNA expression by the Cooper strain and -0.8±0.0-fold 
for the LA strain.  At the 12h time point, both the Cooper strain and the LA strain IL-8 
expression was similar.  The Cooper strain down regulated -1.0±0.0-fold while the LA 
strain had a -1.0±0.0-fold decrease.  IL-8 down regulation increased at the 24h time 
points with the Cooper strain decreasing -3.5±0.1-fold and the LA strain a -2.0±0.1-fold.  
At the 48h time point, the Cooper strain down regulated IL-8 mRNA expression               
-3.8±0.2-fold and the LA strain a value of -3.5±0.151 fold.  The calves used in the study 
had similar results.  For the Cooper infected MDDCs, only 2 calves had viable MDDCs.  
The 3rd calf's MDDCs were not statistically nor biologically significant and was not 
included in the results.  The two calves showed similar down regulatory effects for IL-8 
(Fig 3.10).  For the LA infected MDDCs, all 3 calves had statistically significant results.  
For the first time point at 6hs, all 3 calves had similar down regulation.  Calf #3 had a 
slightly larger down regulation than the other two calves at the 12h time point.  At the 
48h time point calf #1 was slightly less in down regulation than the other two calves (Fig 
3.11).  For IL-10, a peak for the Cooper strain was seen at 48h with -1.5-fold and a peak 
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for the LA strain at 48h with -2.0-fold (Fig 3.12).  For IL-12 a peak was seen at 48h with 
-2.0-fold for the Cooper strain and 48h with -1.9-fold for the LA strain (Fig 3.13). 
BHV-1 Infected MDDC Surface Marker Expression 
 The Cooper strain decreased MHCI expression in mean fluorescence intensity 
(MFI) by 50,000 between the 6h to 24h time points.  No decrease in MFI was seen 
following the LA strain infection (Fig 3.14 A).  The Cooper strain decreased MHCII MFI 
by 250,000, while the LA strain didn't affect expression (Fig 3.14 B).  Finally, the Cooper 
strain infected MDDCs had a slight decrease in CD86 MFI going from about 25,000 to 
20,000 from 6h to 24h time points.  The LA strain had a larger decrease in CD86 MFI 
with about 10,000 less MFI compared to the Cooper strain (Fig 3.14 C).  The controls 
were consistent for all 3 surface markers.  For MHCI (Fig 3.14 A) there was about a 
25,000 difference in MFI for the 3 control time points.  MHCII (Fig 3.14 B) had around a 
100,000 MFI difference between controls.  For CD86 (Fig 3.14 C) there was around a 
10,000 MFI difference between time points. 
 
DISCUSSION 
TCID50 Assay 
 For the production of BHV-1 in the highly susceptible MDBK cells, the TCID50, 
viral titer was seen in both the lysate and supernatant at the 6h time point.  This was true 
for both viruses.  The Cooper strain had a higher viral titer than the LA strain in both the 
lysate and supernatant.  The presence of BHV-1 in the supernatant indicated that viral 
infection, replication, and release is occurring as soon as 6h p.i.  At each time point, the 
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virus titer in the supernatant at each time point was greater than the virus titer in the 
lysate up to 48h.  At 48h the titer was similar in both supernatant and lysate.  Prior to this 
study, the susceptibility of MDDC to BHV-1 viral infection and replication was 
unknown.  Comparing the MDDC TCID50 to the MBDK control, the results indicated 
that viral infection, replication, and release occurred in MDDCs.  This occurred at 6h p.i. 
for both the Cooper strain and the LA strain.  The supernatant viral titer was at 6.5 log10 
for both the Cooper strain and the LA strain at 6h.  There wasn't little difference between 
the 6h time point and 48h time point indicating that the virus replication remains 
consistent between the supernatant and lysate.  These results indicate that MDDCs are 
susceptible to BHV-1, produce less virus than MDBK cells. 
BHV-1 Infected MDDC Cytokine Expression 
 IFN-alpha up regulation had the largest increase in MDDC cytokine expression 
following BHV-1 infection.  This was consistent with previous studies with BHV-1 in 
vivo and in vitro in other cell types.  One study (Höhle et al., 2005) indicated the 
importance IFN-alpha plays in BHV-1 infected animals.  An artificial open reading frame 
for IFN-alpha was created and tested with BHV-1.  The study showed that infected cells 
secreted substantial amounts of IFN-alpha causing an inhibition of BHV-1 replication.  
The antiviral effect was rapid and sustained and showed little or no direct spreading.  
Compared to the other cytokines tested, IFN-alpha had the greatest change in cytokine 
expression.  While the 6h time point wasn't significant for Cooper, a 3.5-fold increase 
was seen by the 48h time point.  The LA strain had an increase starting at 6h, but only a 
2.8-fold increase was seen by the 48h time point.  Interestingly, the calves that had the 
most down regulation for IL-8 had the most up regulation for IFN-alpha.  This shows a 
62 
 
trend that the calves' immune systems remained either better or worse between the 
compared animals for all time points with both viruses and cytokines examined.  The rest 
of the cytokines tested didn't have statistical significance, but still showed significance or 
difference from the control and other virus.  With IFN-beta, an up regulation was 
observed, but much less than seen in IFN-alpha.  The Cooper strain showed significance 
from both the control and the LA strain.  A steady up regulation was seen for both viruses 
with the most significance seen at 6h between the Cooper and LA strains.  With IFN-
gamma, a difference was observed between viruses and control at 6h for the Cooper 
strain and 12h for the LA strain, but little significance was seen.  Significance was 
observed between the two viruses at 48h.  Less expression was seen for IFN-gamma than 
both IFN-alpha and IFN-beta.  Human herpesvirus 8 (HHV-8) targets IL-8, IL-1b, and 
IL-6 of B lymphocytes.  An up regulation of these cytokines occurred (Knowlton, et al., 
2014) in infected B lymphocytes.  Due to the inverse relationship between the 
inflammatory action of cytokines produced by B lymphocytes and DCs, the down 
regulation of these cytokines for MDDCs is consistent with the data.  A down regulation 
of inflammatory cytokines for MDDCs during an infection allows easier movement of 
virus throughout the body.  With less inflammation present, more space is available for 
MDDC movement.  A down regulatory effect for IL-8 was expected due to the role of 
recruiting neutrophils through chemotaxis.  Because chemotaxis helps in virus removal, 
down regulation of IL-8 is important for the Cooper and LA strains.  While neither virus 
had a large down regulation until 24h, down-regulation was seen.  At the 24h time points 
both viruses had a down regulation that was at least 1-fold.  The Cooper strain had almost 
a 2-fold down regulatory effect, but the LA strain had a 1-fold down regulatory effect.  
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Both calves studied with Cooper infected MDDCs were similar which can be explained 
as having biologically similar immune systems because of the same breed.  Calf #1 had 
less of a down regulatory effect than Calf #2 for all time points indicating that it has a 
slightly better MDDC immune response.  With the LA infected MDDCs, a similar trend 
was observed.  Each of the 3 calves were consistent in their down regulation, with Calf 
#1 having the least down regulation of IL-8 and Calf #3 having the most down regulation 
of IL-8.  Down regulation for the Cooper strain was more prominent until the 48h time 
point when both viruses were about equally down regulation IL-8 production.  For IL-1b, 
slight significance in down regulation was seen starting at 6h for both viruses.  At the 24h 
time point, the LA strain had more down regulation than was seen in the Cooper strain, 
but only slightly.  For IL-6, no difference was observed for the Cooper strain, and the LA 
strain showed a slight difference.  Significance was best seen between the two viruses at 
the 12h time point.  With IL-10, significance was seen at all time points.  The interesting 
observation is that the Cooper strain had less down regulation for all time points than the 
LA strain.  The down regulation followed a relatively steady decline for both viruses. The 
6h time point for IL-12 only showed difference from the control and the viruses, 
Significance was first seen at 12h in IL-12 compared to the control, but both viruses had 
no significance between them.  A slight significance was observed for 24h and 48h time 
points, but the LA strain was slightly more down regulated at 24h and the Cooper strain 
was slightly more down regulated at 48h.  Cytokines are necessary in a proper immune 
response.  If an infected MDDC isn't producing the proper cytokines in adequate amounts 
certain responses may not be elicited and part of the immune system might not work.  
The viral infection doesn't want the immune response to work properly causing cytokine 
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expression changes.  This study indicates that cytokine expression is affected by viral 
infection.  However, the MDDCs are able to up or down regulate cytokine production in 
infected cells to help the rest of the immune system fight off the infection. 
BHV-1 Infected MDDC Surface Marker Expression 
 The decrease in surface marker expression in the controls was likely due to the 
lower viability of cells over time.  The decrease in the control MDDCs does not skew the 
results, as the virally infected cells had a larger decrease than the control MDDCs did 
over the time points.  MHCI and MHCII surface markers were expected to be higher than 
CD86 surface markers due to only MDDCs containing CD86 surface markers.  The 
Cooper strain had effects on both MHCI and MHCII surface makers while the LA strain 
didn't.  MHCI and MHCII are crucial for immune responses, and having a decrease can 
cause problems in the immune system.  Both MHCI and MHCII were significantly down 
regulated starting at 2 hours after cell infection using Northern blot (Hinkley et al, 2000.).  
The BHV-1 LA strain is less virulent and may have little effect on marker expression.  
With the CD86 surface marker, the Cooper strain down regulated expression earlier.  The 
Cooper strain didn't have much of a decrease throughout the rest of the experiment.  This 
may indicate that Cooper affects earlier with CD86 than MHCI or MHCII.  The LA strain 
had an effect on CD86 surface marker expression that wasn't measured until the 24h time 
point was roughly equal between the two strains.  This study indicates that there is a 
decrease in virally infected cells.  This is important because without the necessary surface 
markers present, cells are not able to interact with other cells.  Due to this decrease in 
surface markers, an infected MDDC might not elicit as strong as an interaction with other 
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cells or no interaction at all.  If no interaction occurs T and B cells may not activate in 
infections preventing the body to surmount a response. 
Summary 
 IFN-alpha had the greatest up regulation at approximately 12-fold.  IFN-beta had 
a slight up regulation of 2-fold, but IFN-gamma had a negligible up regulation.  The IL 
cytokines all had down regulations around 4-fold.  The Cooper strain had a greater 
overall regulatory compared to the LA strain.  For surface markers, a decrease in MFI 
was observed for MHCI, MHCII, and CD86.  In the TCID50 tests MDDCs were shown to 
be not as susceptible to the Cooper strain and the LA strain than MDBK cells. 
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Fig 3.1. BHV-1 virus production in MDDC and MDBK infected cells: Results of a 
TCID50 assay for MDDCs (A) and MDBK cells (B) showing supernatant titer and cell 
titer. 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
6 hr sup 6 hr cell 12 hr 
sup 
12 hr 
cell 
24 hr 
sup 
24 hr 
cell 
48 hr 
sup 
48 hr 
cell 
Lo
g 
1
0
 
MDDC TCID50 
Cooper TCID50 LA TCID50 Expon. (Cooper TCID50) Expon. (LA TCID50) 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
6 hr sup 6 hr cell 12 hr 
sup 
12 hr 
cell 
24 hr 
sup 
24 hr 
cell 
48 hr 
sup 
48 hr 
cell 
Lo
g 
1
0
 
MDBK TCID50 
Cooper TCID50 LA TCID50 Expon. (Cooper TCID50) Expon. (LA TCID50) 
A 
B 
67 
 
 
Fig 3.2. BHV-1 IFN-Alpha up regulation: BHV-1 Cooper and LA strains IFN-Alpha 
up regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.3. BHV-1 Cooper strain IFN-Alpha up regulation: BHV-1 Cooper strain IFN-
Alpha up regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.4. BHV-1 LA strain IFN-Alpha up regulation: BHV-1 LA strain IFN-Alpha up 
regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.5. BHV-1 IFN-Beta up regulation: BHV-1 Cooper and LA strains IFN-Beta up 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.6. BHV-1 IFN-Gamma up regulation: BHV-1 Cooper and LA strains IFN-
Gamma up regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.7. BHV-1 IL-1b down regulation: BHV-1 Cooper and LA strains IL-1b down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.8. BHV-1 IL-6 down regulation: BHV-1 Cooper and LA strains IL-6 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.9. BHV-1 IL-8 down regulation: BHV-1 Cooper and LA strains IL-8 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.10. BHV-1 Cooper strain IL-8 down regulation: BHV-1 Cooper strain IL-8 
down regulation by calf in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.11. BHV-1 IL-8 down regulation: BHV-1 LA strain IL-8 down regulation by calf 
in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.12. BHV-1 IL-10 down regulation: BHV-1 Cooper and LA strains IL-10 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
 
Fig 3.13. BHV-1 IL-12 down regulation: BHV-1 Cooper and LA strains IL-12 down 
regulation in MDDCs at 0h, 6h, 12h, 24h, and 48h time points. 
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Fig 3.14. The effect of BHV-1 infection on expression of MHCI, MHCII, and CD86 
on MDDC: Mean fluorescence intensity of surface marker expression per cell at 6h, 12h, 
and 24h time points after viral infection of MDDCs for MHCI (A), MHCII (B), and 
CD86 (C). 
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CHAPTER 4: GENERAL CONCLUSION 
 BVDV and BHV-1 are two of the costliest viral diseases in the cattle industry.  
This study was important to show the effects BVDV and BHV-1 have on cytokine 
production.  Prior to this study there was little information on the effect of BVDV and 
BHV-1 infection on MDDC cytokine production.  Both BVDV and BHV-1 affected 
cytokine production with all the cytokines measured, but varied by virus and strains.  For 
BVDV, down regulation of cytokine production of IFN-alpha, IFN-beta, and IFN-gamma 
was shown.  Additionally, down regulation of IL-1a and TNF was shown.  These results 
suggested that a higher virulent strain, 1373, has a greater impact on cytokine regulation 
than a lower virulent strain, 28508.  The cytokines affected are likely to play a more 
important role in BVDV viral infection.  For BHV-1, up regulation of the same cytokines 
was observed.  The rest of the cytokines: IL-1b, IL-6, IL-8, IL-10, and IL-12 were down 
regulated for both viruses.  Similar observations can be made between BVDV and BHV-
1.  The results suggested that a higher virulent BHV-1 strain, Cooper, has a greater 
impact on cytokine regulation than a lower virulent strain, Los Angeles.  More cytokines 
were affected by BHV-1, implying that BHV-1 will affect cytokine regulation more than 
BVDV.  A summary of the cytokine mRNA expression is shown in Fig 4.1.  
Furthermore, in the BVDV study, cattle breed played a role in cytokine regulation.  
Brown Swiss calves are less susceptible to cytokine regulation than Holstein Friesian.  
This may be due to Brown Swiss calves having greater monocyte quantities in their 
blood.  This led to the hypothesis that both viral virulence and cattle breed can impact 
cytokine regulation.  Finally, in the BHV-1 study, the MFI of MHCI, MHCII, and CD86 
decreased over the time points observed.  The results suggested that a highly virulent 
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strain has the greatest effect on MHCI  and MHCII expression.  MFI for CD86 was not 
affected by a high virulent strain, but by a low virulent strain instead. 
 Further investigation of different strains of BVDV and BHV, such as BHV-4 are 
worth investigation.  Both BVDV and BHV have received little investigation on the 
effects different strains have on MDDCs.  Investigating more strains will give a better 
idea on how the viruses interact with MDDCs.  The observations could be drastically 
different compared to other strains in the same viral grouping.  Additionally, a 
comparative study on MDDCs and DCs infected with BVDV and BHV is also worth 
investigating.  The more knowledge on these two economically challenging viruses could 
lead to better methods of treatment and prevention. 
 Additional experiments could focus on T cell interaction between infected 
MDDCs or DCs.  As DCs serve to stimulate naive T cells and activate them, a virally 
infected DC could have a different effect on the naive T cells.  The presentation of the 
antigens to the T cells might not yield as strong of a stimulus as uninfected DC.  Perhaps 
this won't allow the naive T cells to activate.  Furthermore, a virally infected DC might 
change the T cell cytokine yield after activation.  If the naive T cell isn't stimulated as 
well by a virally infected DC, the cytokines produced might be decreased.  Observing T 
cell interaction with virally infected MDDCs or DCs is an good next step to look at how 
different MDDCs and DCs are when infected. 
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Cytokine IFN 
Alpha 
IFN 
Beta 
IFN 
Gamma 
IL-
1a 
IL-
1b 
IL-6 IL-8 IL-
10 
IL-
12 
TNF 
BVDV           
BHV-1           
Table 4.1. BVDV and BHV-1 Cytokine Summary: A summary of cytokine regulation 
with white cells indicating minimal change, red indicating down regulation, dark red 
indicating significant down regulation, green indicating up regulation, and dark green 
indicating significant up regulation. 
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